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I Zusammenfassung 
Eine genaue und reproduzierbare Quantifizierung von Lipidspezies ist von 
entscheidender Bedeutung für ein besseres Verständnis der funktionellen 
Bedeutung von Lipidspezies. Die Massenspektrometrie stellt dafür das 
wichtigste analytische Verfahren dar. Die folgende Arbeit beschreibt die 
Entwicklung einer Fließ-Injektion-Analyse Fourier-Transformation 
Massenspektrometrie Methode (FIA-FTMS) zur Messung und Quantifizierung 
von Lipidspeziesprofilen in biologischen Proben mit einem hohen 
Probendurchsatz. Die Methode wurde an einer Q Exactive Orbitrap mit einer 
maximalen Auflösung von 140,000 bei m/z 200 entwickelt. Um einen hohen 
Probendurchsatz zu erreichen wurde eine einfache Aufarbeitung (Bligh & Dyer 
Extraktion), kurze Messzeiten von weniger als 4 Minuten und eine selbst 
programmierten Daten Auswertung in Microsoft Excel verwendet. 
Ein wichtiger Schritt in der Datenauswertung von lipidomischen Daten stellt die 
Isotopenkorrektur dar, die zum einen für das natürliche Vorkommen der Isotope 
(Isotopenkorrektur Typ I) und zum anderen für den Überlapp des zweiten 
Isotops einer Spezies mit einer zusätzlichen Doppelbindung (Isotopenkorrektur 
Typ II) korrigiert. Durch Experimente mit synthetischen Standards konnte 
gezeigt werden, dass eine Reihe von Lipidspezies von Peak Koaleszenz 
betroffen ist. Dabei handelt es sich um ein Phänomen, welches für Fourier-
Transformation Massenspektrometer als  konstruktive und/oder destruktive 
Interferenz von Peaks beschrieben wurde. Peak Koaleszenz kann bei nah-
isobaren Ionen auftreten, wie z.B. dem Typ II-Überlapp in 
Doppelbindungsserien (m/z 0.00894 für einen Überlapp resultierend aus zwei 
13C-Atomen). Im Rahmen dieser Arbeit konnte gezeigt werden, dass trotz Peak 
Koaleszenz eine akkurate Quantifizierung von Lipidspezies über einen weiten 
Bereich möglich ist. Wie erwartet ist für Spezies mit m/z < 600 keine Typ-II 
Korrektur notwendig, da die Massenauflösung ausreichend für eine Trennung 
der isobaren Peaks innerhalb einer Doppelbindungsreihe ist. Unerwartet war, 
dass für Spezies mit m/z > 800 keine Typ-II Korrektur nötig ist, obwohl isobare 
Spezies hier z.T. vollständig überlappen. Im Massenbereich von m/z 600 bis 
800 kommt es zu einem partiellen Überlapp von isobaren Peaks. Hier konnte 
gezeigt werden, dass mittels „I/A“-Korrektur die Richtigkeit der ermittelten 
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Konzentrationen deutlich verbessert wird. Dafür wird ein Korrekturfaktor aus 
Intensität und Fläche der isobaren Peaks bestimmt und mit der Konzentration 
multipliziert. 
Außerdem konnten wir zeigen, dass Cholesterin Ester (CE) wesentliche 
Unterschiede in der analytischen Response in Bezug auf Kettenlänge, Zahl der 
Doppelbindungen, infundierte CE Gesamtkonzentration und das Vorhandensein 
zusätzlicher Lipidklassen aufweisen. Als Hauptgrund für die Response 
Unterschiede konnten wir Fragmentierungsprozesse in der Ionenquelle 
während der Elektronspray-Ionisation nachweisen. Die Fragmentierung in der 
Ionenquelle nimmt insbesondere mit der Zahl der Doppelbindungen in den CE 
Spezies ab. Mit Hilfe synthetischer Standards konnten Responsefaktoren zur 
Korrektur der CE Spezies berechnet werden. Erst durch Anwendung dieser 
Responsefaktoren konnte eine gute Übereinstimmung von Serum-
Konzentration mittels FTMS und einem zertifizierten enzymatischen Test 
erreicht werden. Die Bestimmung von freiem Cholesterin (FC) erfolgt über die 
gleichzeitige Sammlung und Fragmentierung der Vorläuferionen von FC und 
D7-FC (FIA-MSX/FTMS). Die Quantifizierung mit den spezifischen 
Cholestadiene Fragmenten zeigte im Vergleich mit einer etablierten 
Acetylchlorid-Derivatisierung übereinstimmende Resultate.  
Eine abschließende Methodenvalidierung demonstrierte, dass FIA-FTMS und 
FIA-MSX/FTMS zur Quantifizierung von Lipidspezies in biologischen Proben 
wie Plasma, Serum, Geweben oder Zellhomogenaten in wissenschaftlichen und 
klinischen Studien geeignet sind. Die Methoden überzeugen durch hohe 
Reproduzierbarkeit und ausreichende Sensitivität.  
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II Abstract 
A key requirement to get more insight into the functional role of lipid species is 
their accurate and precise quantification in biological samples. Considering that, 
mass spectrometry provides the main analytical tool. The following work 
describes the development of a flow injection analysis Fourier-Transform mass 
spectrometry (FIA-FTMS) method to analyze and quantify lipid species profiles 
of biological samples in high throughput. The method applied a Q Exactive 
Orbitrap with a maximum resolution of 140,000 at m/z 200, a simple lipid 
extraction (Bligh and Dyer), short analysis times of less than 4 min and an 
automated data evaluation with self-programmed macros in Microsoft Excel.  
Data deconvolution of lipidomic data includes isotope correction as a crucial 
step, which comprises the correction of the natural abundance of isotopes (type 
I effect) and the overlap resulting from the second isotope of a species with one 
additional double bond (type II effect). Experiments with synthetic standards 
revealed peak coalescence for a number of lipid species, a phenomenon 
described for Fourier-Transform mass spectrometry (FTMS) as constructive 
and/or destructive interference of peaks. Peak coalescence occurs for near-
isobaric ions e.g. related to type II overlap in double bond series with m/z 
0.00894 (for isotopic peaks resulting from incorporation of two 13C-atoms). 
Here, we could demonstrate that, despite peak coalescence, accurate 
quantification is possible for a wide range of lipid species. As expected, peaks 
with m/z < 600 require no type II correction due to sufficient mass resolution to 
resolve isobaric peaks within a double bond series. Unexpected, peaks with m/z 
> 800 did not require type II isotope correction despite completely overlapping 
isobaric peaks within a double bond series. In the mass range m/z 600-800, 
accuracy of the concentrations of partially overlapping peaks could be improved 
by the so-called I/A correction (developed in this thesis). The I/A correction 
applies a correction factor that is calculated from the intensity and area of the 
overlapping peaks.  
Furthermore, we could show that, upon full scan FTMS quantification, 
cholesteryl esters (CE) show substantial differences in their analytical response 
depending on the number of double bonds (DB), length of the acyl chain, 
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infused lipid concentration, and other lipid components. A major determinant for 
these response differences is their susceptibility to in-source fragmentation. In 
particular, introduction of DB lowers the degree of in-source fragmentation. 
Moreover, the results obtained by synthetic standards allowed the calculation of 
response factors, whose application corrected for the analytical response 
differences, as the comparison with a certified enzymatic test confirmed. The 
determination of free cholesterol (FC) was performed by simultaneous collection 
and fragmentation of precursor ions of FC and D7-FC (FIA-MSX/FTMS). The 
quantification matched the results obtained with an established acetyl chloride 
derivatization method, which improved signal intensities by ~400 fold.   
Finally, method validation demonstrated that FIA-FTMS and FIA-MSX/FTMS 
are applicable for quantification of lipid species in biological samples used in 
basic science as well as in clinical studies such as cultured cells, tissue 
homogenates, plasma, and serum. The method showed a high reproducibility 
and sufficient sensitivity for precise and accurate quantification.  
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1 Introduction 
1.1 Chemistry and Biology of Mammalian Lipids 
A simple definition for lipids is that they are soluble in nonpolar solvents like 
chloroform or alcohols. However, this definition is quite broad and can be 
misleading since many substances are nowadays regarded as lipid that may 
also be soluble in water, for example bile acid conjugates. Newer definitions 
from LipidMaps (https://www.lipidmaps.org) with the purpose of creating a 
comprehensive classification define lipids as hydrophobic or amphiphatic small 
molecules that may originate entirely or in part by carbanion-based 
condensations of thioesters and/or by carbocation-based condensations of 
isoprene units (Fahy et al., 2005; Fahy et al., 2009). 
1.1.1 Main Categories of Lipids 
In 2005, the LipidMaps consortium has published a chemically based 
classification system for lipids (Fahy et al., 2005). Following the publication, lipid 
species are placed into eight lipid categories: fatty acyls (FA), glycerolipids 
(GL), glycerophospholipids (GP), sphingolipids (SP), sterol lipids (ST), prenol 
lipids (PR), saccharolipids (SL), and polyketides (PK). This chapter will briefly 
introduce the mammalian lipid categories FA, GL, GP, SP, and ST (Figure 1.1). 
 
Figure 1.1 Examples of species of the main mammalian lipid categories. 
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1.1.1.1 Fatty Acyls (FA) 
Fatty acyls are synthesized by chain elongation (addition of C2 units) of an 
acetyl-CoA with a malonyl-CoA or methylmalonyl-CoA group (Fahy et al., 2005). 
Depending on the chemical structure, the lipid category consists of various 
subgroups, for example eicosanoids or fatty alcohols. However, the most 
prominent members are fatty acids, which contain a carboxyl group. The fatty 
acids are classified concerning their degree of saturation, branched chains or 
additional functional groups. In general, fatty acids are main components of 
most natural lipids in the human body and play crucial roles in health and 
disease. First, fatty acids serve as source of energy in the -oxidation. Full 
oxidation of one molecule palmitic acid (C16H32O2) yields in total 106 molecules 
ATP. For comparison, full oxidation of one molecule glucose (C6H12O6) by 
cellular respiration yields in total only 32 molecules ATP. Furthermore, the fatty 
acid composition of membrane lipids is one of the regulatory principles of the 
biophysical membrane properties, which are also important to regulate the 
activity of membrane proteins (Stubbs & Smith, 1984). However, dysregulation 
of the fatty acid homeostasis can lead to severe diseases. For example 
atherosclerosis, neurodegenerative diseases, or various types of cancer are 
often related to an uncontrolled endogenous palmitic acid biosynthesis (Carta, 
Murru, Banni, & Manca, 2017). 
1.1.1.2 Glycerolipids (GL) 
The molecules of this category (GL) are composed of glycerol attached with 
one, two, or three substitutes. The most relevant substitutes are fatty acids 
esterified to glycerol (Coleman & Lee, 2004). In some cases, fatty alcohols can 
be attached via ether bonds to the glycerol. Depending on the number of 
attached fatty acids the lipid classes are referred to as monoradylglycerol, 
diradylglycerol, or triradylglycerol (Liebisch et al., 2013). Further subclasses are 
represented by glycosylradylglycerols, which are characterized by the linkage of 
one or more sugar residues attached via glycosidic linkage. The chemical 
structure of exemplary species of monoacylglycerols (MG), diacylglycerols 
(DG), and triacylglycerols (TG) is shown in Figure 1.2. 
1.1 Chemistry and Biology of Mammalian Lipids 
[3] 
 
Figure 1.2 Examples of mammalian gylcerolipid species.  
The daily consumption of fat in humans is about 90-120 g/day with an 
absorption rate of 95% (Pan & Hussain, 2012). Fats and oils originating from 
animals or plants are mostly consisting of different TG species. The uptake of 
dietary lipids occurs mainly in the small intestine. First step of the intestinal 
digestion is the emulsification with bile salts to make them accessible for the 
hydrolysis by lipases (Hussain, 2014; Mu & Hoy, 2004; Pan & Hussain, 2012). 
Pancreatic lipases hydrolyze TG species resulting in the corresponding fatty 
acids and 2-monoacylglycerol. The free fatty acids are taken up into the 
enterocytes by active transport and/or diffusion processes (Glatz, Luiken, & 
Bonen, 2010). After uptake, TGs are resynthesized at the endoplasmic 
reticulum by acyltransferases before they are either stored in lipid droplets or 
packed into chylomicrons and secreted to the lymph. Triacylglycerols are 
accumulated in adipose tissue and are the major form of energy storage in 
mammals. The energy release is achieved by TG hydrolysis and subsequent -
oxidation of the attached fatty acids.  
1.1.1.3 Glycerophospholipids (GP) 
Glycerophospholipids are characterized by the presence of a phosphate or 
phosphonate group esterified to one hydroxyl group of the glycerol (Fahy et al., 
2005). The main subclasses in eukaryotic cells are phosphatidylcholines (PC), 
phosphatidylethanolamines (PE), phosphatidylglycerols (PG), 
phosphatidylinositols (PI), and phosphatidylserines (PS) (Figure 1.3).  
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Figure 1.3 Examples of mammalian glycerophospholipid species. 
Lipids of this category are the main components of biological membranes 
(Cooper, 2000). These membranes are usually composed of two layers of lipid 
molecules (lipid bilayer). The amphiphilic character of phospholipids, consisting 
of a hydrophilic head group and a lipophilic tail, induces bilayer formation. 
Biological membranes form physical barriers separating the interior of a cell 
from the exterior (plasma membrane) as well as different compartments within a 
cell, for example endoplasmic reticulum, golgi apparatus, or nucleus. 
Furthermore, proteins are incorporated in plasma membranes to regulate active 
transport of molecules and/or signaling processes. The phospholipid 
composition of membranes can be highly diverse for different cell types, 
organelles, and inner/outer membranes (Hishikawa, Hashidate, Shimizu, & 
Shindou, 2014). Structural differences and lipid species composition can have a 
huge influence on membrane fluidity/rigidity and therefore on the regulation of 
cellular processes. Several PC species contain an ether bond at the sn-1 
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position (Paltauf, 1994), which may serve as precursor for the generation of the 
platelet-activating factor (Prescott, Zimmerman, Stafforini, & McIntyre, 2000). 
1.1.1.4 Sterol Lipids (ST) 
The biosynthetic pathway of ST involves the polymerization of dimethylallyl 
pyrophosphate / isopentenyl pyrophosphate (Fahy et al., 2005). The sterol lipids 
can be classified to sterols, steroids, steroid conjugates, secosteroids and bile 
acids. The chemical structure of important sterol lipids is shown in Figure 1.4. 
The most abundant member of the polycyclic sterol group in mammalians is 
cholesterol. Cholesterol is an essential lipid component in mammalian cells and 
occurs mainly as non-esterified, free cholesterol (FC) in membranes and as 
cholesteryl esters (CE) stored in lipid droplets or transported in lipoprotein 
particles (van Meer, Voelker, & Feigenson, 2008).  
 
Figure 1.4 Examples of mammalian sterol lipid species. 
FC has unique biophysical properties, which play together with the 
phospholipids an important role in regulation of membrane fluidity and cellular 
lipid homeostasis (Horton, Goldstein, & Brown, 2002). Small changes in its 
content may influence membrane properties significantly. Moreover, blood and 
lipoprotein cholesterol concentrations are applied in patient diagnostics and 
treatment for decades (Stone et al., 2014). Beside the function within biological 
membranes, cholesterol serves as precursor for steroid hormones, for example 
testosterone. These hormones are powerful signaling molecules that regulate 
various organismal functions. 
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1.1.1.5 Sphingolipids (SP) 
The category of sphingolipids is defined by a long chain base as core structure. 
The simplest class of SL are ceramides, which contain a sphingosine or a 
related base linked to a fatty acid via amide bond. Ceramides are used as 
precursors to form either phospho- or glycosphingolipids by attaching different 
head groups  that provide a number of unique physical properties (Merrill, 
2011). For example mammalian sphingomyelins (SM), ceramides (Cer) and 
hexosylceramides (HexCer) frequently contain a dihydroxy C18 sphingosine 
base but differ by their head groups (Figure 1.5).  
 
Figure 1.5 Exemplary species of important mammalian sphingolipids. 
SP are essential molecules incorporated in membranes and critical signaling 
molecules whose abundance is tightly regulated (Aguilera-Romero, Gehin, & 
Riezman, 2014). Ceramides are extremely hydrophobic and increase the 
molecular order (rigidity) of phospholipid containing membranes (Alonso & 
Goni, 2018). However, ceramides are minor components within the membrane, 
but their physical and chemical properties may induce microdomains (Cer-rich 
platforms) (Staneva, Momchilova, Wolf, Quinn, & Koumanov, 2009). Moreover, 
Cer concentrations may increase by tenfold and higher under stress or 
apoptosis conditions. Therefore, Cer has received considerable interest as key 
regulator of programmed cell death (Alonso & Goni, 2018; Mullen & Obeid, 
2012). 
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1.2 Principles of Mass Spectrometry and Types of Mass 
Spectrometers 
Mass spectrometry is an analytical technique to measure mass-to-charge ratios 
(m/z) of ions. In general, a mass spectrometer consists of an ion source, a 
mass analyzer, and a detector. The ion source is the part of the mass 
spectrometer that ionizes molecules within a sample. Nowadays, the most 
common applied ionization techniques are electro-spray-ionization (ESI), 
atmospheric pressure chemical ionization, and matrix-assisted laser desorption 
ionization (Dass, 2006). The mass analyzer separates the transferred ions 
according to their specific m/z. Several types of mass analyzers have been 
developed and all of them have in common that they use electric and/or 
magnetic fields to resolve ions. Each mass analyzer has its characteristics 
regarding the mass resolution (resolving power), mass accuracy, sensitivity, 
mass range, and analysis speed (scans per time unit). Examples of typically 
used mass analyzers in lipidomics are time-of-flight (TOF) analyzers, 
quadrupole analyzers, and ion trap analyzers. The molecules within a sample 
are ionized, separated according to their specific m/z, and detected by a 
capable detector (for example electron multiplier). 
This work has been performed with a heated ESI-source coupled to a Q 
Exactive Orbitrap mass spectrometer, a hybrid instrument consisting of a 
quadrupole and an Orbitrap mass analyzer using Fourier Transform mass 
spectrometry. The following chapter will briefly introduce the applied techniques. 
1.2.1 Electro-Spray-Ionization 
ESI is a “soft” ionization technique producing intact ions. Therefore, it is 
possible to analyze large and fragile molecules occurring in biological systems, 
like proteins and lipids, without fragmentation. ESI is a convenient technique for 
ionizing polar compounds and is also suitable for any non-polar compound that 
makes a preformed ion in solution (adduct formation). To enter the gaseous 
phase, the sample solution is sprayed by the ESI needle, to which a high 
voltage is applied, creating small droplets that are electrically charged on the 
surface (Figure 1.6). The solvent slowly evaporates increasing the electrical 
charge density in the droplets up to the Rayleigh stability limit. The Rayleigh 
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limit describes the point at which the Coulomb repulsion becomes of the same 
order as the surface tension. Further solvent evaporation results in an instability 
(“Coulomb explosion”) that dissociates the droplets in smaller ones. Finally, 
droplet radius is small enough and the charge density strong enough to desorb 
the ions from the droplet into the ambient gas to enter the mass spectrometer 
(Fenn, Mann, Meng, Wong, & Whitehouse, 1989). 
 
Figure 1.6 ESI process in positive ion polarity mode. Reprinted with permission 
from Thermo Fisher Scientific. Copyright 2008 Thermo Fisher Scientific. 
 
1.2.2 Quadrupole Mass Analyzers 
The quadrupole mass spectrometry was invented in the early 1950s by 
Wolfgang Paul, who was awarded with the Nobel Prize for his discovery many 
years later (1989) (Finnigan, 1994). In general, quadrupole mass analyzers 
consist of four parallel hyperbolic/circular rods (Figure 1.7). A direct current 
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(DC) voltage and a radio frequency (RF) voltage of the same amplitude and 
sign are applied to the electrically connected opposing rods. The DC and RF 
voltages applied to the other rod pair have the same amplitude but differ in their 
polarity. Subjected ions travel down the electric field of the quadrupole. The 
applied ratio of voltages allows certain ions of a specific m/z ratio to reach the 
detector. Ions of different m/z have unstable trajectories and will neutralize by 
colliding with the rods.  
 
Figure 1.7 Schematic of a quadrupole mass analyzer. 
A commonly used mass spectrometer in lipidomics is the triple quadrupole MS. 
This instrument consists of two quadrupole mass analyzers (Q1 and Q3) 
controlled by DC and RF voltages and a third quadrupole, the collision cell (q2) 
to which only a RF voltage is applied (Figure 1.8). The first quadrupole Q1 
selects ions at defined m/z. The following quadrupole q2 is filled with an inert 
gas like argon or nitrogen. The collision with the gas molecules induces 
formation of fragment ions. These fragments are then analyzed by Q3.  
 
Figure 1.8 Schematic of a triple quadrupole mass spectrometer. 
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1.2.3 Orbitrap Mass Analyzers 
The concept of an orbital trapping device for application to mass analysis has 
been first published 2000 by Alexander Makarov (Makarov, 2000). The key 
elements of an Orbitrap are a barrel-like outer electrode and a spindle-like inner 
electrode along the axis (Figure 1.9).  
 
Figure 1.9 Schematic of an Orbitrap and an example of stable ion trajectory. 
Reprinted with permission from (Makarov, 2000). Copyright 2000 American 
Chemical Society. 
The applied electric field consists of a quadrupole field of the trap and an 
additional logarithmic field of the cylindrical capacitor (quadro-logarithmic field). 
The shape of the electrodes and the equipotentials of the quadro-logarithmic 
field induce stable ion trajectories with a harmonic oscillation along the z-axis 
(Makarov, 2000). The angular frequency of this oscillation is only depending 
on the ion-specific m/z ratio and the instrument settings (constant k): 
𝜔 = √
𝑧
𝑚
∗ 𝑘 
Ions of the same m/z ratio will oscillate in-phase along the z-axis for thousands 
of oscillations. There are two different modes of mass analysis in Orbitrap 
instruments. The first one is image current detection using Fourier Transform 
mass spectrometry (FTMS) and the second mode is a detection based on a 
secondary electron multiplier (Figure 1.10).  
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Figure 1.10 Modes of mass analysis in the Orbitrap: (A) Fourier Transform 
mass spectrometry and (B) detection using a secondary electron multiplier. 
Reprinted (adapted) with permission from (Makarov, 2000). Copyright 2000 
American Chemical Society. 
 
1.2.4 The Q Exactive Orbitrap Mass Spectrometer 
The Q Exactive Orbitrap mass spectrometer, which was used for lipid analysis 
in this thesis, combines a high resolution Orbitrap mass analyzer with a 
quadrupole for precursor selection and is therefore referred to as hybrid 
instrument (Figure 1.11). The mode of analysis of the instrument is image 
current detection (FTMS). Two split halves outer electrodes are used to detect 
the image current and a differential amplifier for amplification (Figure 1.10A). 
The application of FT determines the frequency of the harmonic oscillations and 
allows the calculation of m/z ratios of subjected ions (Zubarev & Makarov, 
2013). 
Further components of the Q Exactive are the C-trap (curved linear trap filled 
with nitrogen) and the HCD collision cell (higher-energy collisional dissociation). 
The C-trap dissipates the kinetic energy of injected ions by collision with 
nitrogen molecules and bundles them on the trap axis. The ion bundles are then 
subjected orthogonal to the z-axis of the Orbitrap for FTMS analysis or, if 
MS/MS spectra are acquired, the ions are first transferred to the HCD collision 
cell for ion fragmentation. 
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Figure 1.11 Schematic of the Q Exactive Orbitrap mass spectrometer. 
Reprinted (adapted) with permission from Thermo Fisher Scientific. Copyright 
2012 Thermo Fisher Scientific. 
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1.3 Lipidomics 
1.3.1 Definition and Principles 
The extensive field of “omics” aims at the analysis of biological molecules that 
provide functionality, structure, and/or dynamic procedures to organisms. In 
general, the cascade of omics reaches from the genome through the 
transcriptome, proteome to the metabolome (Davis, Bathe, Schiller, Slupsky, & 
Sawyer, 2011). The field of lipidomics is a subset of metabolomics and has 
recently emerged with the great advances in mass spectrometry (Blanksby & 
Mitchell, 2010; Han, Yang, & Gross, 2012; Lagarde, Geloen, Record, Vance, & 
Spener, 2003). An up to date review by Yang and Han defines lipidomics as 
large-scale study of pathways and networks of cellular lipids in biological 
systems and denotes the actual research as study of structure and function of 
the complete set of lipids (lipidome) in a single cell or organism as well as their 
interaction with other cellular components (Yang & Han, 2016). This involves 
the quantitative molecular characterization of cellular lipid species in biological 
systems. According to several estimations, the lipidome of an eukaryotic cell 
contains up to 100,000 individual molecular lipid species (van Meer, 2005; 
Wenk, 2005; Yetukuri, Ekroos, Vidal-Puig, & Oresic, 2008). Therefore, the 
reliable and accurate quantification of lipid species is a key tenet that requires 
convenient species assignment and depending on the instrument resolution 
isotopic deconvolution (Bielow, Mastrobuoni, Orioli, & Kempa, 2017).  
Cellular lipid composition plays crucial roles in dynamic processes and is 
influenced by physiological, pathophysiological, and/or environmental 
conditions. An imbalance in lipid homeostasis for example is involved in various 
pathophysiological conditions such as Alzheimer disease, atherosclerosis, 
cardiovascular diseases or diabetes (Dawber, Moore, & Mann, 1957; Ekroos, 
Janis, Tarasov, Hurme, & Laaksonen, 2010; Hopkins et al., 2003; Kohno, 
Keenan, Ntambi, & Miyazaki, 2018; Mapstone et al., 2014). Furthermore, lipids 
are involved in basic processes essential for tumor development, for example 
cell growth, proliferation, differentiation, and motility (Santos & Schulze, 2012). 
Several mass spectrometric lipidomic methods with scientific and clinical 
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application have been developed over the last decades (Hu & Zhang, 2018; 
Krautbauer & Liebisch, 2018; Matysik & Liebisch, 2017). 
1.3.2 LC-based vs Shotgun Lipidomics 
In general, biological samples comprise a complex mix of different lipids 
considering the number of classes, subclasses and species composition. A 
common way to reduce the complexity of lipid extracts for MS based 
approaches is the utilization of chromatographic separation, most important 
liquid chromatography (LC) (Myers, Ivanova, Milne, & Brown, 2011; Schott, 
Krautbauer, Horing, Liebisch, & Matysik, 2018; Sokol et al., 2013). In contrast, 
shotgun lipidomics is a direct-infusion based approach without any pre-
separation prior to mass spectrometric analysis. The crude lipid extract is 
directly infused into a mass spectrometer and the identification of individual 
species relies on their accurately determined masses on MS level or specific 
fragment ions in MS/MS spectra (Han & Gross, 2003, 2005). The application on 
MS level gained increasing interest with the development of high resolution 
mass spectrometers. The technical simplicity allows the detection of multiple 
lipid classes in parallel in a single analysis with rather short measurement times. 
Moreover, the lipid concentration and composition of analytes in shotgun 
approaches does not change over time simplifying species quantification (Yang 
& Han, 2016). A summary of advantages and limitations of LC-based MS and 
shotgun MS lipidomic approaches is shown in Figure 1.12. 
Nowadays, shotgun MS analysis of biological samples is routinely applied to 
investigate samples in high throughput (Jung et al., 2011). However, to our 
knowledge, all lipidomic approaches on a high resolution FTMS instrument use 
chip-based nano-ESI. (Ejsing et al., 2009; Grzybek et al., 2019; Schuhmann et 
al., 2017; Surma et al., 2015). Accordingly, the application described in this 
thesis presents the first application using a conventional LC pump system to 
infuse crude lipid extracts of biological samples, as it is commonly performed on 
other instruments (Bowden, Bangma, & Kucklick, 2014; Liebisch, Lieser, 
Rathenberg, Drobnik, & Schmitz, 2004). 
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Figure 1.12 Comparison of LC-based and shotgun MS lipidomic approaches. 
 
1.3.3 Lipid Nomenclature 
Lipid nomenclature of this work is based on the comprehensive classification 
system for lipids presented by the International Lipid Classification and 
Nomenclature Committee (Fahy et al., 2005; Fahy et al., 2009). Additionally, 
shorthand notations reflecting the structural information of lipid species derived 
from mass spectrometric analysis have been applied (Liebisch et al., 2013). For 
example, PC 34:1 denotes the lipid class (PC, phosphatidylcholine) and 
indicates the total number of carbon atoms (34) and double bonds (1) of the 
acyl chains. However, it does not provide further information about the 
individual fatty acyl chain composition. Possible acyl combinations for example 
could be PC 16:0/18:1 and PC 18:1/16:0 (different sn-positions of the fatty 
acyls). The application of high resolution mass spectrometry allows a clear 
distinction between ester and ether bonds. An ether bond is noted with an O- as 
for example PC O-34:1.  
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1.4 Aim of this Work 
Aim of this PhD thesis is the development of a FIA-FTMS method to quantify 
lipid species in biological samples. The instrument of interest is a Q Exactive 
Orbitrap high resolution mass spectrometer (with a resolution of 140,000 at m/z 
200) equipped with a heated electro-spray-ionization source coupled to a 
conventional LC isocratic pump system. The method development includes lipid 
extraction, instrumental method, and data processing in an untargeted 
approach.  
Data deconvolution comprises the development of an isotope correction 
algorithm to correct for the abundance of the monoisotopic peak (type I effect) 
and for the overlap of the second isotope peak of a species with the 
monoisotopic peak of a species with one less double bond (type II effect), as 
well as the correction of species-specific response effects observed for 
cholesteryl esters.  
Furthermore, the method should be applicable to biological samples of clinical 
and scientific studies. Therefore, lipid species quantification should be accurate 
and reproducible allowing high throughput of samples. 
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2 Materials and Methods 
2.1 Chemicals 
Chloroform, 2-propanol, and hexane were purchased from Roth (Karlsruhe, 
Germany), methanol from Merck (Darmstadt, Germany), and 2,2,4-
trimethylpenthane from Honeywell (Seelze, Germany). All solvents were HPLC 
grade. Water (aqua ad iniectabilia) for lipid extraction was purchased from B. 
Braun (Melsungen, Germany). Ammonium formate, CE, FC, and PC standards 
were purchased from Sigma-Aldrich (Taufkirchen, Germany). 
[25,26,26,26,27,27,27-D7]-cholesterol was obtained from Cambridge Isotope 
Laboratories (Andover, MA, U.S.A.) with isotope purity higher than 98%. All CE 
standards have been dissolved in hexane/2-propanol (1:1 v/v), cholesterol and 
D7-cholesterol were dissolved in chloroform/methanol (9:1 v/v) with 1 g/L 
butylated hydroxytoluene. The concentrations of the dissolved CE standards 
were determined by gas chromatography mass spectrometry (GC-MS) using a 
certified fatty acid methyl ester (FAME) mix (Supelco 37 component FAME mix) 
from Sigma-Aldrich (Taufkirchen, Germany) as described previously (Ecker, 
Scherer, Schmitz, & Liebisch, 2012). TG and DG standards were purchased 
from Larodan (Solna, Sweden) and dissolved in 2,2,4-trimethylpenthane/2-
propanol (3:1 v/v). Cardiolipin (CL), Cer, HexCer, LPC, LPE, PE, PG, PI, PS, 
and SM standards were purchased from Avanti (Alabaster, Alabama, USA) and 
dissolved in chloroform. Acetyl chloride of the highest analytical grade available 
was purchased from Fluka (Buchs, Switzerland). 
 
2.2 Internal Standards 
Quantification of lipid species was performed by addition of non-endogenous 
internal standards. The composition of pre-built IS mixtures for analysis of 
plasma and serum samples, and cell and tissue samples is listed in Table 2.1. 
The spike volume added for plasma/serum samples and cell/tissue samples 
was 25 µL and 50 µL, respectively.  
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Table 2.1 Composition of internal standard mixtures added to plasma and 
serum samples or cell and tissue samples. 
Species MW Plasma/Serum IS Cell/Tissue IS 
Unit [g/mol] [ng/spike] [nmol/spike] [ng/spike] [nmol/spike] 
CE 17:0 638.60 2500 3.91 500 0.78 
CE 22:0 708.68 2500 3.53 500 0.71 
Cer 32:1;2 509.48 12.5 0.025 50 0.10 
Cer 35:1;2 551.53 12.5 0.023 50 0.091 
CL 56:0 1240.85 
  
100 0.081 
DG 28:0 512.44 300 0.59 250 0.49 
DG 40:0 680.63 300 0.44 250 0.37 
D7FC 393.40 2500 6.35 3750 9.53 
HexCer 30:1;2 643.50 20 0.031 60 0.093 
HexCer 35:1;2 713.58 20 0.028 60 0.084 
LPC 13:0 453.29 375 0.83 50 0.11 
LPC 19:0 537.38 375 0.70 50 0.093 
LPE 13:0 411.24 25 0.06 50 0.12 
PC 28:0 677.50 875 1.29 1250 1.85 
PC 44:0 901.75 1250 1.39 1250 1.39 
PE 28:0 635.45 100 0.16 500 0.79 
PE 40:0 803.64 100 0.12 500 0.62 
PG 28:0 666.45 
  
125 0.19 
PG 40:0 834.63 
  
125 0.15 
PI 34:0 838.56 125 0.15 250 0.30 
PS 28:0 679.44 75 0.11 750 1.10 
PS 40:0 847.63 75 0.088 750 0.88 
SM 30:1;2 646.50 250 0.39 500 0.77 
TG 51:0 848.78 1250 1.47 900 1.06 
TG 57:0 932.88 1250 1.34 900 0.96 
 
 
2.3 Laboratory Equipment 
2.3.1 Laboratory at the University Hospital Regensburg 
Centrifuge Megafuge 1.0R........................................ Heraeus (Hanau, Germany) 
Glass Centrifuge Tubes ........................... Hecht-Assistant (Sondheim, Germany) 
Filtration Milli-Q UF Plus ........................... Merck Millipore (Darmstadt, Germany) 
GCMS-QP2010 ............................................................ Shimadzu (Kyoto, Japan) 
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GentleMACS Dissociator ............ Miltenyi Biotec (Bergisch Gladbach, Germany) 
GentleMACS 10 mL Tubes ......... Miltenyi Biotec (Bergisch Gladbach, Germany) 
PAL autosampler ....................................... CTC Analytics (Zwingen, Switzerland) 
Pyrex Culture Tubes ........................................... SciLabware Ltd (Riverside, UK) 
Q-Exactive Orbitrap ........................ Thermo Fisher Scientific (Bremen, Germany) 
Quattro Ultima MS ................. Micromass Communications Inc (Manchester, UK) 
Sample Vials (1.5 mL volume) ................................. VWR (Darmstadt, Germany) 
Screw Caps (PTFE naturelle)................................... VWR (Darmstadt, Germany) 
Screw Caps (PTFE, Sil, PTFE) ................................ VWR (Darmstadt, Germany) 
Siemens Dimension Vista ..... Siemens Health Care GmbH (Erlangen, Germany) 
SpeedVac ................................................................. Christ (Osterode, Germany) 
Tecan Genesis RSP 150 ................... Tecan Group Ltd (Männedorf, Switzerland) 
UltiMate 3000 isocratic pump ....... Thermo Fisher Scientific (Waltham, MA, USA) 
Ultrasonic Desintegrator .................. B. Braun Melsungen (Melsungen, Germany) 
Ultrasonicbath Sonorex ..............................................Bandelin (Berlin, Germany) 
Vortex Genie 2 ......................................... Bender & Hobein (Zurich, Switzerland) 
 
2.3.2 Mass Spectrometry at the University of Southern Denmark 
The analysis of CE response was additionally performed on an Orbitrap Fusion 
Tribrid from Thermo Fisher Scientific (San Jose, CA, USA) equipped with a 
TriVersa NanoMate from Advion Biosciences (Ithaca, NY, USA). The 
experiments were performed in collaboration with Prof. Christer Ejsing at the 
University of Southern Denmark in Odense. 
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2.4 Biological Samples 
Human plasma and serum samples were collected from residual patient 
material after clinical routine diagnostics.  
Primary human skin fibroblasts were cultured in Dulbecco’s Modified Eagle 
Medium (DMEM) supplemented with L-glutamine, nonessential amino acids, 
and 10% fetal calf serum at 5% CO2 in a humidified incubator at 37°C as 
described previously (Drobnik et al., 1999).  
Murine liver samples were collected from residual material analyzed for various 
scientific studies. The different liver samples were either solitary homogenized 
or pooled homogenates in MeOH:H2O (1:1 v/v). 
 
2.5 Sample Preparation 
2.5.1 Tissue Homogenization 
Organic tissues were weighed and cut into 50-300 mg pieces. MeOH:H2O 
(1:1 v/v) was added to achieve a concentration of 50 mg/mL. The tissue was 
processed 1-3 times in the GentleMACS Dissociator with the pre-installed 
“protein_01” program (90 seconds per cycle). All tissues and samples were 
stored at -80°C. 
2.5.2 Lipid Extraction 
Internal standards (see 2.2 Internal Standards) were added to a glass centrifuge 
tube and the solvent was removed by vacuum centrifugation prior to lipid 
extraction. A sample amount of 10 µL serum, 10 µL plasma, cell homogenates 
containing 100 µg of protein or tissue homogenates containing a wet weight of 
2 mg were subjected to lipid extraction. The samples were extracted according 
to the procedure described by Bligh and Dyer (Bligh & Dyer, 1959). An amount 
of 800 µL H2O (adjusted for aqueous samples) and 3 mL B&D solution 
(MeOH/CHCl3 2:1 v/v) were added. The mixture was vortexed for 5 sec and 
incubated for 1 h at room temperature. Subsequently, 1 mL H2O and 1 mL 
CHCl3 was added, mixed and centrifuged for 10 min at 4,000 rpm (17,860 g). 
An amount of 500 µL of the separated chloroform phase was transferred into a 
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1.5 mL glass sample vial by a pipetting robot (Tecan Genesis RSP) and 
vacuum dried. The residues were dissolved in 1.2 mL of 7.5 mM ammonium 
formate in chloroform/methanol/2-propanol (1:2:4 v/v/v). 
 
2.6 Lipid Species Quantification by FIA-FTMS 
Lipid species quantification was performed by direct flow injection on a hybrid 
quadrupole-Orbitrap mass spectrometer (Q Exactive) equipped with a heated 
electro-spray-ionization source coupled to an UltiMate 3000 isocratic LC pump. 
2.6.1 FIA-FTMS 
The ion source was operated using the following settings: spray voltage of 
3.5 kV (positive ion mode) and 2.5 kV (negative ion mode), S-lens RF level of 
50, capillary temperature of 250 °C, aux gas heater temperature of 100 °C, and 
settings of 15 and 5 for sheath gas and aux gas, respectively. All data were 
acquired in profile mode. Amounts of 50 µL of the reconstituted sample extracts 
were injected by a PAL autosampler equipped with an isocratic LC pump. 
Chloroform/methanol/2-propanol (1:2:4 v/v/v) was delivered at an initial flow rate 
of 100 µL/min until 0.25 min, followed by 10 µL/min for sample analysis until 
2.6 min and a wash out with 300 µL/min until 3.1 min. All FTMS data were 
recorded with a maximum injection time (IT) of 200 ms, an automated gain 
control (AGC) of 1×106, three microscans, and a target resolution of 140,000 at 
m/z 200. MS/MS was applied for quantification of free cholesterol (FC) using an 
isolation window of 1 Da with normalized collision energy of 10%, an IT of 
100 ms, an AGC of 1×105, and a target resolution of 140,000 at m/z 200. 
2.6.2 Lipid Class Determination 
The list of lipid classes determined by FIA-FTMS is shown in Table 2.2. Positive 
ion mode data were analyzed for 0.7 min resulting in 31 averaged scans (three 
microscans). FC was analyzed for 0.4 min in positive ion mode by multiplexing 
(MSX) ammoniated precursor ions of cholesterol (m/z 404.39) and the 
corresponding internal standard D7-cholesterol (m/z 411.43). Negative ion mode 
data were acquired in two scan events, m/z 400-650 and m/z 520-960. The 
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lower mass range was analyzed for 0.55 min (22 averaged scans) and the 
higher mass range for 0.6 min (25 averaged scans). 
Table 2.2 Lipid classes determined by FIA-FTMS. 
Lipid Class Lipid Category Experiment Ion Mode Adduct Mass Range [m/z] 
CE ST FTMS positive [M + NH4]
+
 500-1000 
Cer SP FTMS negative [M + HCOO]
-
 520-960 
DG GL FTMS positive [M + NH4]
+
 500-1000 
FC ST MSX/FTMS positive [M + NH4]
+
 404.39 / 411.43 
HexCer SP FTMS negative [M + HCOO]
-
 520-960 
LPA GP FTMS negative [M - H]
-
 400-650 
LPC GP FTMS negative [M + HCOO]
-
 400-650 
LPC O- GP FTMS negative [M + HCOO]
-
 400-650 
LPE GP FTMS negative [M - H]
-
 400-650 
LPE O- GP FTMS negative [M - H]
-
 400-650 
PC GP FTMS negative [M + HCOO]
-
 520-960 
PC O- GP FTMS negative [M + HCOO]
-
 520-960 
PE GP FTMS negative [M - H]
-
 520-960 
PE O- GP FTMS negative [M - H]
-
 520-960 
PG GP FTMS negative [M - H]
-
 520-960 
PI GP FTMS negative [M - H]
-
 520-960 
PS GP FTMS negative [M - H]
-
 520-960 
SM SP FTMS negative [M + HCOO]
-
 520-960 
TG GL FTMS positive [M + NH4]
+
 500-1000 
 
2.6.3 Data Processing and Quantification 
2.6.3.1 Calculation of Isotopic Probabilities 
The calculation of accurate masses and probabilities of isotopic peaks was 
performed with emass (Rockwood & Haimi, 2006). The atomic isotope 
probabilities have been adapted to the International Union of Pure and Applied 
Chemistry (Rosman & Taylor, 1998). The import of lipid species, sum formula 
and adduct was supported by self-programmed Microsoft Excel 2010 Macros. 
2.6.3.2 Peak Assignment and Offset Correction 
The peak assignment and offset correction of data recorded on the Q Exactive 
Orbitrap was performed in two steps with the ALEX software (Husen et al., 
2013). In a first step, the output (.raw) files were converted into txt-files omitting 
the first 14 and last 26 scans. Afterwards, the peak information in the txt-files 
was screened for possible lipid species in an untargeted approach, including the 
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information of isotopic peaks. The offset correction of FTMS experiments was 
performed by averaging the mass deviation of three internal standards of each 
ion mode and mass range (Table 2.3), with a tolerance of m/z 0.01. The offset 
correction of the MSX/FTMS experiment was performed with the protonated 
cholestadiene fragment of D7-FC with m/z 376.3955. The actual lipid species 
assignment and intensity picking was performed with a tolerance of m/z 
0.0045 after offset correction. The area for the assigned peak was determined 
from baseline to baseline, independent of the selected m/z-tolerance. 
Table 2.3 Internal standards used for offset correction of FTMS experiments. 
Species Adduct m/z 
positive ion mode m/z 500-1000 
CE 17:0 [M + NH4]
+
 656.6340 
TG 51:0 [M + NH4]
+
 866.8171 
PC 44:0 [M + H]
+
 902.7572 
negative ion mode m/z 400-650 
LPE 13:0 [M - H]
-
 410.2313 
LPC 13:0 [M + HCOO]
-
 498.2837 
LPC 19:0 [M + HCOO]
-
 582.3776 
negative ion mode m/z 520-960 
Cer 35:1;2 [M + HCOO]
-
 596.526 
PE 28:0 [M - H]
-
 634.4453 
PC 28:0 [M + HCOO]
-
 722.4978 
 
2.6.3.3 Isotope Correction 
The isotope correction was performed by self-programmed Macros in Microsoft 
Excel 2010. The Macros corrected for the abundance of the monoisotopic peak 
(type I effect (Han & Gross, 2001)). The type II effect derives from the overlap of 
the second isotope peak of a species with the monoisotopic peak of a species 
with one less double bond (DB) (Ejsing et al., 2006). This isotope effect was not 
corrected for species with m/z < 600 or m/z > 800. Species with m/z 600-800 
were corrected by multiplying species intensity with an intensity/area correction 
factor (I/A correction). The calculated I/A for a given m/z was determined with 
the following exponential decaying function: 
𝐼
𝐴
(𝑐𝑎𝑙𝑐𝑑) = 5.212 ∗ 𝑒
4169
(m/z+678.4) 
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The I/A correction factor for constellations where the measured I/A of the 
second isotope of the species with one additional DB (Species+1DB M+2) is 
smaller or even than the I/A of the monoisotopic species with one less DB 
(Species+0DB M+0) was calculated: 
I
A
𝐶𝑜𝑟𝑟𝑒𝑐𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 =
𝐼
𝐴 (𝑐𝑎𝑙𝑐𝑑)
𝐼
𝐴 (𝑀 + 0 𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑)
 
For constellations where the measured I/A (Species+1DB M+2) > I/A 
(Species+0DB M+0), the I/A (measured) was calculated with the average of the 
monoisotopic species and the second isotope: 
I
A
𝐶𝑜𝑟𝑟𝑒𝑐𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 =
𝐼
𝐴
(𝑐𝑎𝑙𝑐𝑑) ∗ 2
𝐼
𝐴
(𝑀 + 0 𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑) +
𝐼
𝐴 (𝑀 + 2 𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑)
 
Limitation was a false picked intensity of the monoisotopic species (see 3.1 
Isotope Correction Algorithm for FIA-FTMS). The correction was only applied for 
a target resolution of 140,000 at m/z 200. Data recorded at lower resolutions 
were corrected for the type II effect by a stepwise correction based on 
theoretical isotope distributions (Haimi, Uphoff, Hermansson, & Somerharju, 
2006; Han & Gross, 2005; Liebisch et al., 2004). 
2.6.3.4 Sodium Correction 
The sodium correction was applied for species analyzed as protonated adduct. 
These adducts are overlapping with the sodium adduct of a species of the same 
lipid class with two carbon atoms less and three DB less (e.g. PC 36:4 [M+H]+ 
and PC 34:1 [M+Na]+ with a m/z of 0.00248). The fraction of sodium adduct 
within a sample was determined by averaging the intensity ratio of 
[M+Na]+/[M+H]+ of both internal standards of the corresponding lipid class. The 
ratio was used to calculate the intensity of sodium adduct of the overlapping 
species and subsequently subtracted from the protonated species.  
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2.6.3.5 Quantification 
The quantification was performed with non-endogenous internal standards 
(Table 2.1) by multiplication of the spiked IS amount with the analyte-to-IS ratio 
of the intensities after isotope correction.  
2.6.3.6 Cholesteryl Ester Response Correction 
The CE response correction was performed by multiplying calculated species 
specific response factors on the quantified CE species concentration (Horing, 
Ejsing, Hermansson, & Liebisch, 2019). The response factors were calculated 
with the following equations (C is the number of carbon atoms of the acyl chain; 
DB is the number of double bonds of the acyl chain; A is the matrix factor): 
𝑟𝑒𝑠𝑝𝑜𝑛𝑠𝑒(𝑐𝑎𝑙𝑐𝑑) = [0.049 ∗ 𝐶 + 0.57 ∗ 𝐷𝐵] ∗ 𝐴 
𝑟𝑒𝑠𝑝𝑜𝑛𝑠𝑒 𝑓𝑎𝑐𝑡𝑜𝑟 =
1
𝑟𝑒𝑠𝑝𝑜𝑛𝑠𝑒(𝑐𝑎𝑙𝑐𝑑)
 
The matrix factor was 0.95 for saturated species, 0.91 for monounsaturated 
species and 0.89 for polyunsaturated species (see 3.2.2 Analytical Response of 
Cholesteryl Esters quantified by FIA-ESI-FTMS). 
2.6.3.7 Background Correction 
The background correction was performed with three internal standard blanks 
analyzed within the same batch. The concentration of lipid species detected in 
the IS blanks were averaged and subtracted from the sample. 
 
2.6.4 Method Validation 
The validation of FIA-FTMS included intraday and day-to-day reproducibility, 
determination of limits of quantification (LOQ), and evaluation of the dynamic 
range of quantification.  
To evaluate the intraday reproducibility, the samples were extracted five times 
and subjected to quantitative FIA-FTMS (MSX/FTMS for FC). The experiment 
was repeated on four different days separated evenly within a four month period 
to evaluate the day-to-day reproducibility. The coefficients of variation (CV) 
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were determined for human plasma, human fibroblast cells, and murine liver 
samples. 
The LOQ were determined functionally as previously described for LC-
MS/HRMS methods (Liebisch & Matysik, 2015; Schott et al., 2018). Non-
endogenous internal standard species pairs were analyzed by FIA-FTMS 
(CE 17:0 and CE 22:0, DG 28:0 and DG 40:0, PC 28:0 and PC 44:0, TG 51:0 
and TG 57:0). CE 17:0, DG 28:0, PC 28:0, and TG 51:0 were used as internal 
standards for quantification and CE 22:0, DG 40:0, PC 44:0, and TG 57:0 were 
spiked with decreasing concentrations. The concentrations of the titrated 
species are indicated in the corresponding figures. The results were fitted by a 
power function. The LOQ was defined as concentration where either the CV 
reached 20% or the accuracy left the range of 80-120%. The LOQ were 
determined in human plasma and for CE additionally in human skin fibroblast 
cells. The LOQ of free cholesterol (MSX/FTMS) were determined by titration of 
the synthetic D7-FC standard using the endogenous amount of FC as internal 
standard for quantification. 
The evaluation of the dynamic range of quantification was performed by spike 
experiments of the synthetic standards LPE 18:1, LPC 18:1, DG 36:1, CE 18:1, 
Cer 42:2;2, SM 36:2;2, PC 36:2 and TG 54:1. The measured concentration was 
plotted against the spiked in concentration and was fitted by a linear function. 
The experiment was performed without matrix, with human plasma, human skin 
fibroblast cells, and murine liver samples. The highest spike concentration (in 
vial) was 0.68 pmol/µL for LPE 18:1, 5.37 pmol/µL for LPC 18:1, 6.16 pmol/µL 
for DG 36:1, 7.94 pmol/µL for CE 18:1, 0.36 pmol/µL for Cer 42:2;2, 3.4 pmol/µL 
for SM 36:2;2, 3.3 pmol/µL for PC 36:2, and 4.75 pmol/µL for TG 54:1. The 
concentration of the infusate was calculated by dividing the amount added to 
the extraction in nmol by the dilution of 5.598 during extraction.  
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2.7 Instrument Response of Cholesteryl Esters 
2.7.1 Preparation of Standard Mixtures and Matrix Spikes 
For determination of instrument response a mixture of CE species was 
prepared composed of a homologous series of five saturated species varying in 
chain length (CE 10:0, CE 14:0, CE 16:0, CE 18:0, and CE 22:0), three 
monounsaturated species (CE 16:1, CE 18:1, and CE 24:1), and two 
polyunsaturated species (CE 18:2 and CE 18:3) to obtain a homologous series 
varying in the number of DB (CE 18:0-CE 18:3). CE 17:0 was used as internal 
standard for quantification (3.18 nmol, corresponding to 0.57 pmol/µL in-vial 
concentration). The concentration of stock solutions was determined by GC-MS 
of fatty acid methyl esters as described previously (Ecker et al., 2012). The CE 
mixture was measured in concentration range 1.6-22.8 pmol/µL total CE. The 
highest level had the following concentrations [pmol/µL]: CE 10:0 = 3.2, CE 14:0 
= 2.87, CE 16:0 = 2.43, CE 16:1 = 3.08, CE 18:0 = 2.36, CE 18:1 = 2.39, 
CE 18:2 = 0.85, CE 18:3 = 0.95, CE 22:0 = 2.13, and CE 24:1 = 2.11. The 
species were dissolved in hexane/2-propanol (1:1 v/v). 
The TG mixture with a total TG concentration of 5.4 pmol/µL was composed of 
[pmol/µL]: TG 42:0 = 1.23, TG 48:0 = 1.11, TG 51:0 = 1.05, TG 54:3 = 1.02, and 
TG 57:0 = 0.96. 
The PC mixture with a total PC concentration of 5.8 pmol/µL was composed of 
[pmol/µL]: PC 28:0 = 1.32, PC 34:0 = 1.18, PC 34:2 = 1.18, PC 36:4 = 1.14, and 
PC 44:0 = 0.98. 
2.7.2 FIA-FTMS using a Q Exactive Orbitrap 
Lipid quantification was performed on a Q Exactive Orbitrap equipped with a 
heated electrospray ionization source coupled to a conventional isocratic pump. 
The parameters of the FIA-FTMS method are described under 2.6.1 FIA-FTMS. 
For determination of in-source fragmentation, the mass range was set to m/z 
350-760 in positive ion mode. 
2.7.3 Nano-ESI-FIA-FTMS using an Orbitrap Fusion 
The measurements on an Orbitrap Fusion were performed in the laboratory of 
Prof. C. Ejsing at the University of Southern Denmark in Odense. Samples were 
2.8 Evaluation of Isotope Correction Algorithm 
[28] 
infused with the chip-based robotic nanoflow ion source TriVersa NanoMate at 
a flow rate of 200 nL/min into an Orbitrap Fusion Tribrid with a resolution of 
450,000 at m/z 200. Full scan FTMS data were acquired in positive ion mode 
for 1 min with a scan range of m/z 470-1030 using profile mode, a max IT of 
100 ms, AGC of 1×105, three microscans, and a target resolution setting of 
450,000.  
2.7.4 Data Processing and Determination of Response 
The peak assignment and offset correction was performed as described earlier 
(2.6.3.2 Peak Assignment and Offset Correction). Detected species were 
corrected for the abundance of the monoisotopic peak (type I effect (Han & 
Gross, 2001)) and for the type II effect by a stepwise correction based on 
theoretical isotope distributions (Haimi et al., 2006; Han & Gross, 2005; Liebisch 
et al., 2004). Species quantification was performed after isotope correction as 
described in 2.6.3.5 Quantification. 
The instrument response was defined as molar ratio: 
𝑟𝑒𝑠𝑝𝑜𝑛𝑠𝑒 =
𝑛 (𝑑𝑒𝑡𝑒𝑐𝑡𝑒𝑑)[𝑚𝑜𝑙]
𝑛 (𝑒𝑥𝑝𝑒𝑐𝑡𝑒𝑑)[𝑚𝑜𝑙]
 
 
2.8 Evaluation of Isotope Correction Algorithm 
2.8.1 Preparation of Standard Mixtures and Matrix Spikes 
Two standard mixtures were prepared. The mixture “M0” contained saturated 
species of different lipid classes and was composed of: LPE 18:0 
(0.018 pmol/µL), LPC 18:0 (0.18 pmol/µL), DG 36:0 (0.18 pmol/µL), CE 18:0 
(0.18 pmol/µL), SM 36:1;2 (0.18 pmol/µL), Cer 42:1;2 (0.018 pmol/µL), and 
TG 54:0 (0.18 pmol/µL). The mixture “M1” was composed of the corresponding 
species of the same lipid class with exactly one additional DB: LPE 18:1 
(0.018 pmol/µL), LPC 18:1 (0.18 pmol/µL), DG 36:1 (0.18 pmol/µL), CE 18:1 
(0.18 pmol/µL), SM 36:2;2 (0.18 pmol/µL), Cer 42:2;2 (0.018 pmol/µL), and 
TG 54:1 (0.18 pmol/µL). 
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A volume of 25 µL of both mixtures subjected to lipid extraction, corresponding 
to 0.018 pmol/µL (0.1 nmol added to lipid extraction) LPE and Cer, and 
0.18 pmol/µL (1 nmol added to lipid extraction) LPC, DG, CE, SM and TG, was 
defined as ratio M1:M0 = 1:1. Samples were analyzed with a constant amount 
of the M0 mixture and variable amounts of the M1 mixture. Samples with a 
M1:M0 ratio ranging from 0:1 up to 25:1 were analyzed. The concentration of 
the infusate was calculated by dividing the amount added to the extraction in 
nmol by the dilution of 5.598 during extraction. The serum/plasma IS was added 
to the extraction for quantification (Table 2.1). 
2.8.2 FIA-FTMS using a Q Exactive Orbitrap 
The isotope correction experiments were performed on a Q Exactive Orbitrap 
equipped with a heated electrospray ionization source coupled to a 
conventional isocratic pump. The parameters of the instrumental method are 
described under 2.6.1 FIA-FTMS.  
2.8.3 Data Processing  
The peak assignment and offset correction was performed as described earlier 
(2.6.3.2 Peak Assignment and Offset Correction). Detected species were 
corrected for the abundance of the monoisotopic peak (type I effect (Han & 
Gross, 2001)). For the type II isotope effect, three different correction algorithms 
were compared. The “corrected” values were corrected for the type II effect by a 
stepwise correction based on theoretical isotope distributions (Haimi et al., 
2006; Han & Gross, 2005; Liebisch et al., 2004). The “uncorrected” data were 
not corrected for the type II effect. The “I/A corrected” values were corrected by 
multiplying species intensity with an intensity/area correction factor as described 
in 2.6.3.3 Isotope Correction. Species quantification was performed after 
isotope correction as described in 2.6.3.5 Quantification.  
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3 Results and Discussion 
3.1 Isotope Correction Algorithm for FIA-FTMS 
The most frequent occurring isotopic overlap in lipidomics spectra is the overlap 
of a monoisotopic species (Species+0DB M+0 – in the following referred to as 
M+0) with the second isotope of a species of the same lipid class and same 
number of C-atoms with one additional double bond (Species+1DB M+2 – in the 
following referred to as M+2), which we will referred to as double bond 
ambiguity (DBA) (Bielow et al., 2017). The peak shape and apex position of the 
species affected by DBA are depending on the instrument resolution, the 
abundance of both species, and the isotopic fidelity (Almeida, Pauling, Sokol, 
Hannibal-Bach, & Ejsing, 2015; Bielow et al., 2017; Kaufmann & Walker, 2012). 
To correct for this effect, we analyzed samples with a constant amount of the 
M0-mixture (saturated species) with variable amounts of the M1-mixture 
(species with one additional DB), as it is described in the experimental section 
(2.8 Evaluation of Isotope Correction Algorithm). 
3.1.1 Peak Picking and Constellations 
The first important step for the development of an isotope correction algorithm is 
the intensity picking. For peak assignment, we applied a m/z-tolerance of 
±0.0045 after lock-mass correction. The selected tolerance accounts for half the 
mass difference of the double bond overlap (m/z 0.00894) resulting from 
incorporation of two 13C-atoms into the specie with one additional double bond. 
This represents the most frequent M+2 isotope overlap due to the high natural 
abundance of 13C with 1.07%. Using this setting, the ALEX software picks the 
intensity either at the apex, or, if not present within the m/z-tolerance, at m/z 
(expected) ±0.0045. The following peak constellations could be differentiated 
(illustrated in Figure 3.1).  
First Case: The intensity of M+0 is picked at the apex within the selected m/z-
tolerance and the intensity of M+2 is picked at m/z (expected) +0.0045. 
Second Case: Both intensities are picked at the apex within the corresponding 
m/z-tolerance. Peaks of both species are partially or completely separated. 
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Third Case: The intensity of M+0 is picked at m/z (expected) -0.0045 and the 
intensity of M+2 is picked at the apex within the m/z-tolerance. 
 
Figure 3.1 Peak picking and constellations. Peak constellation and picking of 
intensity illustrated for CE 18:1 M+2 and CE 18:0 M+0. The intensities are 
picked either at the apex (triangles) or at peak flank at m/z (expected) +/-
0.0045. The m/z-tolerance of ±0.0045 for intensity picking of CE 18:1 M+2 and 
CE 18:0 M+0 is displayed in orange and blue, respectively. The spike ratio of 
the monoisotopic species is indicated in the figure legend. A target resolution of 
R=100,000 was chosen for the simulation. 
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The peak constellation and the respective case for peak picking are depending 
on the following factors: 1) the intensity ratio of both peaks (modified here by 
the spike amount of the M1-mix), 2) the fractional abundance of the M+2 
isotope, and 3) the mass resolution. The fractional abundance of M+2 and mass 
resolution increase and decrease with m/z, respectively. Therefore, spectra of 
specie-pairs with DBA were evaluated for different lipid classes (each separated 
by approximately m/z 100) at different spike ratios of the M1/M0-mixture (Figure 
3.2). The spectra were recorded at a target resolution of 140,000 at m/z 200. Of 
note, the resolution of Orbitrap instruments decreases with increasing m/z 
following a square root function. At higher m/z mass resolution is not sufficient 
to separate isobaric peaks at any of the tested spike ratios (see TG 54:1 M+2 
and TG 54:0 M+0). With increasing spike amounts of TG 54:1, the peak 
maximum of TG 54:0 M+0 shifted towards the expected mass of TG 54:1 M+2 
at m/z 908.8550. Analogously, the peak constellation changed from first case to 
third case. A third case was already assigned at spike ratio M1/M0 of 5:1due to 
the high abundance of 21.1% for the M+2 isotopic peak of TG 54:1.  
At lower m/z (LPC and CE) M+2 and M+0 peaks were at least partially 
separated, when the peak ratio allowed the detection of both isobaric peaks. 
When one of the isobaric peaks significantly prevailed, both peaks could not be 
resolved. However, for the resulting unresolved peak, the apex did not shift in 
m/z. For species with m/z < 600 we could only detect first and second cases, for 
species with m/z > 800 we could only detect first and third cases, and within the 
m/z-range 600-800 we could assign all three cases. This fits very well to our 
expectation because with a mass resolution setting of 140,000 FWHM (full 
width at half maximum) (at m/z 200) a peak width of 0.00894 Da at half height 
(corresponding to the mass difference of DBA) should be observed for peaks 
around m/z 678. This calculation is based on the square root function for mass 
resolution of Orbitrap analyzers (Makarov et al., 2006).  
Interestingly, for lipid species which center around m/z 678 peak resolutions 
were observed which exceed the expected resolution (non-spiked sample) upon 
appearance of M+2 isobaric peaks as for example for CE 18:0 from expected 
82,600 up to 105,400 and SM 36:1;2 from expected 76,900 up to 106,700 
(Figure 3.2). While the resolution of LPE and LPC was not influenced by 
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addition of M+2, the resolution of TG 54:0 decreased slightly due to peak 
broadening. 
 
Figure 3.2 Mass spectra of the DB overlap of selected specie-pairs recorded at 
R=140,000 at m/z 200 on a Q Exactive. The figure illustrates changes of peak 
shape and shifting maxima induced by increasing abundance of the second 
isotope of the Species+1DB. Of note, spectra shown have not been offset 
corrected at this point. 
3.1.2 Intensity/Area Ratio 
Shotgun lipidomic data are commonly based on the analysis of peak intensities. 
An advantage of the ALEX software (Husen et al., 2013) is the possibility to 
obtain the information of peak areas. The peak area is determined from 
baseline to baseline and therefore independent of the selected m/z-tolerance. 
By recording both parameters, we noticed several advantages using 
intensity/area ratios. The experimentally determined I/A ratios of various 
species are displayed in Figure 3.3 for m/z range 400-1000. For these data, 
lipid species were selected that were not affected by DBA or other potential 
isobaric overlaps. Positive/negative ion mode, various target ions and ion 
abundances as well as sample matrixes were considered. Despite these vast 
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differences, the I/A ratio was only influenced by the physical mass to charge 
attribute. The m/z dependency of I/A ratios could be described by an 
exponential decaying function, which is correlating with the m/z dependent 
resolution of Orbitrap instruments. 
 
Figure 3.3 Determination of I/A ratios in m/z range 400-1000 recorded on a Q 
Exactive at R=140,000 at m/z 200. The I/A ratios were determined for the 
following overlap-free lipid species (in ascending m/z): LPE 13:0, LPE 18:2, 
LPE 18:0, LPC 13:0, LPC 16:1, Cer 32:1;2, CE 10:0, LPC 18:0, TG 30:0, 
LPC 19:0, CE 14:0, DG 36:0, TG 36:0, CE 18:0, PC 28:0 [M+H]+, Cer 42:1;2, 
PC 28:0 [M+HCOO]-, TG 42:0, CE 24:1, SM 36:1;2, TG 48:0, PC 44:0 [M+H]+,  
TG 54:0, PC 44:0 [M+HCOO]-, and TG 60:0. 
Furthermore, the I/A ratios were highly reproducible for isolated peaks at a 
given target resolution. A reduction of the selected target resolution decreased 
the I/A ratios as expected, half resolution resulted in half I/A ratios. This 
reproducibility allows the detection of peak impurities. Partially overlapping 
species or contaminations decrease the I/A ratio significantly due to an 
increased peak area including both peaks (resulting from baseline to baseline 
determination of peak areas) but only the intensity of one of the peaks. In 
contrast, peak intensities of near-isobaric interferences led to peak coalescence 
induced losses of peak intensity. This phenomenon will be explained in detail in 
the next chapter. 
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3.1.3 Comparison of Isotope Correction Algorithms  
Several software tools have been developed to process lipidomic data (LipidQA 
(Song, Hsu, Ladenson, & Turk, 2007), LIMSA (Haimi et al., 2006), FAAT 
(Leavell & Leary, 2006), LipID (Hubner, Crone, & Lindner, 2009), LipidSearch 
(Houjou, Yamatani, Imagawa, Shimizu, & Taguchi, 2005), LipidView (Ejsing et 
al., 2006), LipidInspector (Schwudke et al., 2006), LipidXplorer (Herzog et al., 
2012)). Some of the mentioned algorithms contain a built-in isotope correction. 
Nevertheless, software is typically optimized to support a certain instrument or 
application. Therefore, we decided to perform data processing, including 
isotope correction, with self-programmed Excel Macros in an automated way. 
To evaluate the accuracy of isotope correction, we analyzed samples with a 
constant spike of the M0-mixture against increasing spike amounts of the M1-
mixture and compared the three isotope correction algorithms “corrected”, 
“uncorrected” and “I/A corrected” as described in the materials and method 
section (2.8 Evaluation of Isotope Correction Algorithm). 
The analysis of LPE, LPC, DG, CE, Cer, SM, and TG (in ascending m/z order) 
is shown in Figure 3.4, Figure 3.5, Figure 3.6, Figure 3.7, Figure 3.8, Figure 3.9, 
and Figure 3.10, respectively. Of note, all data were corrected for the type I 
isotope effect (Han & Gross, 2001) independent of the applied isotope 
correction algorithm. Additionally, species quantification of all cases was 
performed with the picked intensity of the quantified, monoisotopic species.   
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Figure 3.4 Quantification of LPE 18:0 at increasing concentrations of LPE 18:1 
at target resolution of 140,000 at m/z 200. Panel A shows the quantification of 
isotope type II corrected (circles), uncorrected (triangles), and I/A corrected 
(squares) data. The dashed line indicates the spiked amount of LPE 18:0. Panel 
B displays the intensity/area ratio of LPE 18:0 and the second isotope of 
LPE 18:1. The dashed line indicates the calculated I/A of m/z 480.3096 
(calculated with the exponential function, Figure 3.3). The color code describes 
the case of peak assignment. Each point represents the average of n = 3 
technical replicates ± SD.  
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Figure 3.5 Quantification of LPC 18:0 at increasing concentrations of LPC 18:1 
at target resolution of 140,000 at m/z 200. Panel A shows the quantification of 
isotope type II corrected (circles), uncorrected (triangles), and I/A corrected 
(squares) data. The dashed line indicates the spiked amount of LPC 18:0. 
Panel B displays the intensity/area ratio of LPC 18:0 and the second isotope of 
LPC 18:1. The dashed line indicates the calculated I/A of m/z 568.362 
(calculated with the exponential function, Figure 3.3). The color code describes 
the case of peak assignment. Each point represents the average of n = 3 
technical replicates ± SD.  
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Figure 3.6 Quantification of DG 36:0 at increasing concentrations of DG 36:1 at 
target resolution of 140,000 at m/z 200. Panel A shows the quantification of 
isotope type II corrected (circles), uncorrected (triangles), and I/A corrected 
(squares) data. The dashed line indicates the spiked amount of DG 36:0. Panel 
B displays the intensity/area ratio of DG 36:0 and the second isotope of 
DG 36:1. The dashed line indicates the calculated I/A of m/z 642.6031 
(calculated with the exponential function, Figure 3.3). The color code describes 
the case of peak assignment. Each point represents the average of n = 3 
technical replicates ± SD.  
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Figure 3.7 Quantification of CE 18:0 at increasing concentrations of CE 18:1 at 
target resolution of 140,000 at m/z 200. Panel A shows the quantification of 
isotope type II corrected (circles), uncorrected (triangles), and I/A corrected 
(squares) data. The dashed line indicates the spiked amount of CE 18:0. Panel 
B displays the intensity/area ratio of CE 18:0 and the second isotope of 
CE 18:1. The dashed line indicates the calculated I/A of m/z 670.6497 
(calculated with the exponential function, Figure 3.3). The color code describes 
the case of peak assignment. Each point represents the average of n = 3 
technical replicates ± SD.  
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Figure 3.8 Quantification of Cer 42:1;2 at increasing concentrations of 
Cer 42:2;2 at target resolution of 140,000 at m/z 200. Panel A shows the 
quantification of isotope type II corrected (circles), uncorrected (triangles), and 
I/A corrected (squares) data. The dashed line indicates the spiked amount of 
Cer 42:1;2. Panel B displays the intensity/area ratio of Cer 42:1;2 and the 
second isotope of Cer 42:2;2. The dashed line indicates the calculated I/A of 
m/z 694.6355 (calculated with the exponential function, Figure 3.3). The color 
code describes the case of peak assignment. Each point represents the 
average of n = 3 technical replicates ± SD.  
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Figure 3.9 Quantification of SM 36:1;2 at increasing concentrations of 
SM 36:2;2 at target resolution of 140,000 at m/z 200. Panel A shows the 
quantification of isotope type II corrected (circles), uncorrected (triangles), and 
I/A corrected (squares) data. The dashed line indicates the spiked amount of 
SM 36:1;2. Panel B displays the intensity/area ratio of SM 36:1;2 and the 
second isotope of SM 36:2;2. The dashed line indicates the calculated I/A of 
m/z 775.5971 (calculated with the exponential function, Figure 3.3). The color 
code describes the case of peak assignment. Each point represents the 
average of n = 3 technical replicates ± SD.  
3.1 Isotope Correction Algorithm for FIA-FTMS 
[42] 
 
Figure 3.10 Quantification of TG 54:0 at increasing concentrations of TG 54:1 
at target resolution of 140,000 at m/z 200. Panel A shows the quantification of 
isotope type II corrected (circles), uncorrected (triangles), and I/A corrected 
(squares) data. The dashed line indicates the spiked amount of TG 54:0. Panel 
B displays the intensity/area ratio of TG 54:0 and the second isotope of 
TG 54:1. The dashed line indicates the calculated I/A of m/z 908.8641 
(calculated with the exponential function, Figure 3.3). The color code describes 
the case of peak assignment. Each point represents the average of n = 3 
technical replicates ± SD.  
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3.1.3.1 Type II Correction of Isotopic Overlap 
First thing to notice, the “corrected” values of all species pairs were remarkably 
overcorrected at higher spike amounts of the species with one additional double 
bond. For species at low m/z, we expect that application of type II correction 
results in too low concentrations because mass resolution is sufficient to 
separate M+2 and M+0 isobaric peaks. Thus, intensities of M+0 are picked at 
the apex and should not be influenced by the M+2 peak. Similarly, we expect 
that for slightly higher m/z despite mass separation is not sufficient to clearly 
separate M+2 and M+0 (e.g. SM 36:1;2 with m/z 775.5971; Figure 3.2). 
Unexpectedly, even for completely overlapping species, as observed for TG 
(Figure 3.2), application of type II correction resulted in significant 
overcorrection at higher intensities of M+2. This indicates that the intensities of 
the M+0 and M+2 are not behaving additively. Of note, the applied correction 
algorithm based on theoretical isotope distributions is commonly used for other 
systems (Haimi et al., 2006; Han & Gross, 2005; Liebisch et al., 2004). 
3.1.3.2  Concentrations without Type II Correction 
To further understand the previously mentioned phenomenon, we evaluated 
concentrations without application of isotope type II correction. The 
“uncorrected” concentrations fitted mostly very well to the target concentrations. 
Especially LPE 18:0 (m/z 480.3096, Figure 3.4), LPC 18:0 (m/z 568.362, Figure 
3.5), and TG 54:0 (m/z 908.8641, Figure 3.10) showed accurate values with a 
low deviation to the target concentration up to high spike amounts of the M1-
mixture. Although, for the third case the intensity for M+0 is not picked at the 
apex but from the peak flank, concentrations of TG 54:0 were in good alignment 
with the target concentration. However, we would not recommend using 
concentrations calculated this way since shifts in m/z and/or peak shape will 
change resulting concentrations substantially.  
For DG 36:0 (m/z 642.6031, Figure 3.6), CE 18:0 (m/z 670.6497, Figure 3.7), 
Cer 42:1;2 (m/z 694.6355, Figure 3.8), and SM 36:1;2 (m/z 775.5971, Figure 
3.9) the uncorrected quantification matched the target values very well for a first 
case. Concentrations calculated for second case were below target 
concentrations even though peaks were partially separated and increased 
values could be expected due to the partial peak overlap.  
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3.1.3.3 Peak Coalescence in FTMS 
We did not expect that both, type II isotope correction of overlapping peaks (e.g. 
for TG 54:0) results in significantly too low concentrations, and uncorrected 
concentrations of partially overlapping peaks fit very well to target 
concentrations. A potential explanation for these observations could be 
destructive (and/or constructive) interference of ions described for iontrap 
instruments using FTMS (Fourier-Transform mass spectrometry) (Aizikov, 
Mathur, & O'Connor, 2009; Huang, Tiedemann, Land, McIver, & Hemminger, 
1994; Nakata, Hart, & Peterson, 2010). This effect occurs when two near-
isobaric ion populations oscillate initially with slightly different frequencies and 
these populations start to coalesce after a number of oscillations. However, the 
individual ion frequency is not detectable anymore and a coupled oscillating 
frequency will be measured instead. The number of oscillations leading to peak 
coalescence of two ion populations is abundance dependent. It is described that 
destructive interferences can result in a distorted relative isotopic abundance 
(RIA) and is depending on the mass resolution (Almeida et al., 2015; Kaufmann 
& Walker, 2012). This may explain the shift of the m/z of unresolved ions 
towards the m/z of the dominating ion. Moreover, it provides a potential 
explanation why the intensity of these overlapping peaks seems to represent 
only the intensity of the dominating ion and not as expected the sum of both 
ions. Instead of an increased intensity some peaks appear broader. 
3.1.3.4 The “I/A Correction” 
We aimed to get more accurate concentrations for peaks affected by peak 
coalescence induced losses of intensity which center around m/z 678. As these 
peaks appear to experience a change in resolution, the idea was to use an 
intensity and area based type of correction, which was termed in the following 
as I/A correction. The following formulas were developed empirically to achieve 
the most accurate concentrations. 
For samples with higher abundance of the monoisotopic species M+0 (up to the 
point of intersection of I/A ratios) the correction factor was calculated with the 
following equation based on the measured and the expected I/A: 
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I
A
𝐶𝑜𝑟𝑟𝑒𝑐𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 (𝑀 + 0) =
𝐼
𝐴 (𝑐𝑎𝑙𝑐𝑑)
𝐼
𝐴 (𝑀 + 0 𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑)
 
When the M+2 ion is dominating over the M+0, the I/A measured of both 
species (M+0 and M+2) was applied for concentration correction: 
I
A
𝐶𝑜𝑟𝑟𝑒𝑐𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟(𝑀 + 0) =
𝐼
𝐴
(𝑐𝑎𝑙𝑐𝑑) ∗ 2
𝐼
𝐴
(𝑀 + 0 𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑) +
𝐼
𝐴 (𝑀 + 2 𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑)
 
The application of this correction reduced the deviation of quantification of 
DG 36:0 (m/z 642.6031, Figure 3.6), CE 18:0 (m/z 670.6497, Figure 3.7), 
Cer 42:1;2 (m/z 694.6355, Figure 3.8), and SM 36:1;2 (m/z 775.5971, Figure 
3.9)  to a minimum. I/A correction practically only affects concentrations when 
the measured I/A deviates from the expected (=calculated). Such deviations 
occur with increasing intensities of M+2 ions for coalescent peaks. For case one 
and two constellations, the I/A correction appears to result in more accurate 
concentrations. Obviously, correction is also accurate for constellations with a 
dominating M+2 ion when I/A of both ions M+0 and M+2 were used for 
correction. As discussed above we would not recommend using results from a 
third case constellation because the intensity for M+0 is not picked at the apex 
but from the peak flank. When mass resolution is sufficient to separate isobaric 
peaks as for the tested LPE and LPC species, uncorrected concentrations are 
more accurate than I/A corrected. Therefore, we would recommend applying the 
I/A correction only for coalescent peaks, which is in our setting a mass range of 
about m/z 600-800. 
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3.1.4 Resolution dependent Isotope Correction 
As demonstrated earlier, quantification of data corrected for the type II effect 
was too low for all analyzed m/z at a resolution setting of 140,000 at m/z 200, 
most likely due to peak coalescence of near-isobaric M+0 and M+2 ions. Since 
peak coalescence was described as a mass resolution dependent 
phenomenon, M1/M0-mixtures were also analyzed at resolutions settings of 
70,000 and 35,000 at m/z 200. Our expectation was that for lower mass 
resolution the overlapping peaks represent the intensities of both M+0 and M+2 
ions which afford type II isotopic correction to achieve accurate concentrations. 
The quantification of LPE 18:0, LPC 18:0, DG 36:0, and CE 18:0 is shown in 
Figure 3.11 and the quantification of the higher m/z species Cer 42:1;2, 
SM 36:1;2, and TG 54:0 is displayed in Figure 3.12. In contrast to the above-
described evaluation, here, for third case constellations (orange color) the 
intensity was picked at the apex of the M+2 ion to base the evaluation on the 
presumably more correct coalescent ion intensity picked in the M+2 mass 
window. As expected, a decrease in mass resolution resulted in more accurate 
(type II corrected) concentrations for all analyzed lipid species. That lyso-
species require lower mass resolution to converge to target concentrations fits 
also very well to a resolution-dependent peak coalescence model. Even third 
case assignments using the intensity from the apex of the M+2 peak followed 
the expectations.  However, here one should keep in mind that the parameters 
for peak picking were not adapted to lower resolutions settings. 
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Figure 3.11 Quantification of (A) LPE 18:0 m/z 480.3096, (B) LPC 18:0 m/z 
568.362, (C) DG 36:0 m/z 642.6031, and (D) CE 18:0 m/z 670.6497 at 
increasing spike amounts of the corresponding species+1DB recorded on a Q 
Exactive at resolution settings of 140,000, 70,000, and 35,000 (m/z 200). All 
data were corrected for the type II effect (“corrected”). The dashed line indicates 
the target value of the saturated species. Third case constellations used the 
apex intensity of the M+2. Each point represents the average of n = 3 technical 
replicates ± SD.  
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Figure 3.12 Quantification of (A) Cer 42:1;2 m/z 694.6355, (B) SM 36:1;2 m/z 
775.5971, and (C) TG 54:0 m/z 908.8641 at increasing spike amounts of the 
corresponding species+1DB recorded on a Q Exactive at resolution settings of 
140,000, 70,000, and 35,000 (m/z 200). All data were corrected for the type II 
effect (“corrected”). The dashed line indicates the target value of the saturated 
species. Third case constellations used the apex intensity of the M+2. Each 
point represents the average of n = 3 technical replicates ± SD.  
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3.1.5 Influence of Sample Matrix 
FIA-FTMS should be applicable for quantification of samples used in basic 
science as well as in clinical studies. The analyzed samples usually contain 
plenty of various analytes that may influence lipid species quantification. To 
verify the presented isotope correction and quantification in biological samples, 
the M1/M0 spike experiment was performed in human plasma, murine liver, and 
human skin fibroblast samples. The basal concentration of lipid species present 
in the different matrices was determined by three technical replicates (CV’s 
< 3% for all species). Additionally, PC 36:2 was added to the M1-mixture and 
PC 36:1 to the M0-mixture providing a further species pair at m/z 832.6073 
(PC 36:1 analyzed as [M+HCOO]-).  
The analysis of LPE 18:0, LPC 18:0, DG 36:0, CE 18:0, Cer 42:1;2, SM 36:1;2, 
PC 36:1, and TG 54:0 are shown in Figure 3.13, Figure 3.14, Figure 3.15, 
Figure 3.16, Figure 3.17, Figure 3.18, Figure 3.19, and Figure 3.20, 
respectively. In general, data evaluation of murine liver (panel B), human 
plasma (panel C), and human skin fibroblast samples (panel D) matched very 
well the results obtained for the synthetic standard samples (panel A) for the 
corresponding type of isotope correction. This is independent of basal amounts 
already present in the matrices for the M+0 and/or M+2 species. For example, 
the basal concentration of SM 36:1;2 determined by FTMS in human plasma 
was 0.033 ±0.001 pmol/µL. The I/A corrected values were in good agreement 
with the target value of SM 36:1;2 (dotted line) representing the sum of the 
spiked amount (0.13 pmol/µL) and the basal concentration (Figure 3.18C). 
Furthermore, similar trends of I/A ratios were observed in the synthetic standard 
and matrix samples. However, some exceptions are apparent from the figures 
that should be mentioned in detail.  
First, LPE 18:0 quantification in murine liver samples (Figure 3.13B) showed 
almost identical values for all applied isotope corrections (corrected, 
uncorrected, and I/A corrected) and these values were also matching with the 
target value of LPE 18:0 representing the sum of spiked amount 
(0.034 pmol/µL) and basal concentration (0.59 pmol/µL). The high amount of 
LPE 18:0 compared to the low amount of LPE 18:1 M+2 (highest spike of 
LPE 18:1 was 0.54 pmol/µL, with an isotopic fractional abundance of 4.69%) led 
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to first case constellations with negligible influence of the second isotope on 
LPE 18:0 quantification. Noticeably, the measured and calculated I/A ratios of 
LPE 18:0 M+0 were almost identical leading to an I/A correction factor of about 
1 and virtually no correction.  
Second, the I/A corrected values of DG 36:0 in human plasma (Figure 3.15C) 
were ~4-fold higher than the target value (0.22 pmol/µL). The I/A ratio of 
DG 36:0 used for response factor calculation was  ~one fourth of the I/A (calcd) 
with 122.4. As already mentioned, the peak area used for calculation of I/A 
ratios includes all peaks that are not baseline resolved to the species of interest. 
In this case, a contamination located at the shoulder (to lower m/z) of the 
second isotope of DG 36:1 elevated the peak area significantly resulting in an 
inaccurate I/A correction. Considering an automated quantification, our data 
processing Macro will recognize these implausible I/A ratios and label the 
results accordingly. For such species the use the uncorrected concentrations is 
recommended.  
Third exception is shown by the quantification of CE 18:0 in human plasma 
(Figure 3.16C). The lipid profile of human plasma is well characterized and 
cholesteryl esters are one of the main lipid classes (Bowden et al., 2017; Sales 
et al., 2016). The FTMS determined concentration of CE 18:1 in the used 
plasma was 1.62 ±0.02 pmol/µL. CE 18:1 has a fractional abundance of 12.68% 
for the second isotope. Hence, the increased abundance of CE 18:1 M+2 led to 
a shift to higher ratios of CE 18:1 M+2/CE 18:0 for each individual sample in 
comparison to the matrix free sample. Therefore, we could not detect a first 
case constellation for the investigated spike range. However, I/A corrected 
concentrations of CE 18:0 matched very well the target value similar as 
demonstrated for matrix free, liver, and cell samples. 
The analysis of PC 36:1 m/z 832.6073 in murine liver, human plasma, and 
human skin fibroblast cells is shown in Figure 3.19. As described above for 
other lipid classes, the “corrected” values were significantly overcorrected due 
to peak coalescence. Most accurate concentrations were achieved without 
further correction, similar to that shown for the quantification of TG 54:0 at m/z 
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908.8641 (Figure 3.20). Again concentrations calculated from third case 
constellations are not reliable. 
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Figure 3.13 Quantification of LPE 18:0 m/z 480.3096 at increasing spike 
amounts of LPE 18:1 m/z 478.2939 recorded (A) without matrix and spiked on 
(B) murine liver, (C) human plasma, and (D) human skin fibroblast samples 
using a mass resolution setting of 140,000 at m/z 200. The dashed line in the 
upper panel indicates the spiked amount of LPE 18:0 and in the lower panel the 
I/A (calcd) of m/z 480.3096. The dotted line (upper panel) represents the target 
concentration of LPE 18:0 (spiked-in and basal sample amount). Each point 
represents the average of n = 3 technical replicates ± SD.  
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Figure 3.14 Quantification of LPC 18:0 m/z 568.362 at increasing spike 
amounts of LPC 18:1 m/z 566.3463 recorded (A) without matrix and spiked on 
(B) murine liver, (C) human plasma, and (D) human skin fibroblast samples 
using a mass resolution setting of 140,000 at m/z 200. The dashed line in the 
upper panel indicates the spiked amount of LPC 18:0 and in the lower panel the 
I/A (calcd) of m/z 568.362. The dotted line (upper panel) represents the target 
concentration of LPC 18:0 (spiked-in and basal sample amount). Each point 
represents the average of n = 3 technical replicates ± SD.  
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Figure 3.15 Quantification of DG 36:0 m/z 642.6031 at increasing spike 
amounts of DG 36:1 m/z 640.5875 recorded (A) without matrix and spiked on 
(B) murine liver, (C) human plasma, and (D) human skin fibroblast samples 
using a mass resolution setting of 140,000 at m/z 200. The dashed line in the 
upper panel indicates the spiked amount of DG 36:0 and in the lower panel the 
I/A (calcd) of m/z 642.6031. The dotted line (upper panel) represents the target 
concentration of DG 36:0 (spiked-in and basal sample amount). Each point 
represents the average of n = 3 technical replicates ± SD.  
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Figure 3.16 Quantification of CE 18:0 m/z 670.6497 at increasing spike 
amounts of CE 18:1 m/z 668.6340 recorded (A) without matrix and spiked on 
(B) murine liver, (C) human plasma, and (D) human skin fibroblast samples 
using a mass resolution setting of 140,000 at m/z 200. The dashed line in the 
upper panel indicates the spiked amount of CE 18:0 and in the lower panel the 
I/A (calcd) of m/z 670.6497. The dotted line (upper panel) represents the target 
concentration of CE 18:0 (spiked-in and basal sample amount). Each point 
represents the average of n = 3 technical replicates ± SD.  
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Figure 3.17 Quantification of Cer 42:1;2 m/z 694.6355 at increasing spike 
amounts of Cer 42:2;2 m/z 692.6199 recorded (A) without matrix and spiked on 
(B) murine liver, (C) human plasma, and (D) human skin fibroblast samples 
using a mass resolution setting of 140,000 at m/z 200. The dashed line in the 
upper panel indicates the spiked amount of Cer 42:1;2 and in the lower panel 
the I/A (calcd) of m/z 694.6355. The dotted line (upper panel) represents the 
target concentration of Cer 42:1;2 (spiked-in and basal sample amount). Each 
point represents the average of n = 3 technical replicates ± SD.  
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Figure 3.18 Quantification of SM 36:1;2 m/z 775.5971 at increasing spike 
amounts of SM 36:2;2 m/z 773.5814 recorded (A) without matrix and spiked on 
(B) murine liver, (C) human plasma, and (D) human skin fibroblast samples 
using a mass resolution setting of 140,000 at m/z 200. The dashed line in the 
upper panel indicates the spiked amount of SM 36:1;2 and in the lower panel 
the I/A (calcd) of m/z 775.5971. The dotted line (upper panel) represents the 
target concentration of SM 36:1;2 (spiked-in and basal sample amount). Each 
point represents the average of n = 3 technical replicates ± SD.  
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Figure 3.19 Quantification of PC 36:1 m/z 832.6073 at increasing spike 
amounts of PC 36:2 m/z 830.5917 spiked on (A) murine liver, (B) human 
plasma, and (C) human skin fibroblast samples using a mass resolution setting 
of 140,000 at m/z 200. The dashed line in the upper panel indicates the spiked 
amount of PC 36:1 and in the lower panel the I/A (calcd) of m/z 832.6073. The 
dotted line (upper panel) represents the target concentration of PC 36:1 
(spiked-in and basal sample amount). Each point represents the average of 
n = 3 technical replicates ± SD.  
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Figure 3.20 Quantification of TG 54:0 m/z 908.8641 at increasing spike 
amounts of TG 54:1 m/z 906.8484 recorded (A) without matrix and spiked on 
(B) murine liver, (C) human plasma, and (D) human skin fibroblast samples 
using a mass resolution setting of 140,000 at m/z 200. The dashed line in the 
upper panel indicates the spiked amount of TG 54:0 and in the lower panel the 
I/A (calcd) of m/z 908.8641. The dotted line (upper panel) represents the target 
concentration of TG 54:0 (spiked-in and basal sample amount). Each point 
represents the average of n = 3 technical replicates ± SD.  
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3.1.6 Summary of Isotope Correction Algorithm for FIA-FTMS 
The lipidomic analysis of biological samples by FIA-FTMS using our platform 
typically comprises lipid classes in mass range of m/z 400-1000 (listed in Table 
2.2). A series of spike experiments revealed that intensities of near-isobaric 
species may behave not additive, most likely due to peak coalescence, a 
phenomenon occurring in iontrap FTMS. This effect is mass resolution 
depended. Since reduction of mass resolution will result in a potential risk of 
isobaric overlap of analytes, the performance of isotopic correction algorithms 
was evaluated at the highest mass resolution setting of 140,000 (at m/z 200). 
This mass resolution is sufficient to resolve isobaric peaks resulting from DBA 
up to m/z 600 without peak coalescence affecting their intensities. Therefore, as 
expected, no further correction of isotopic overlap is necessary below m/z 600. 
The evaluated lipid species demonstrated that peak coalescence occurs within 
a mass range of approximately m/z 600-800 resulting in decreased 
concentrations. These concentrations could be corrected by I/A correction 
introduced here to get closer to target concentrations. An unexpected finding 
was that the peaks in range of m/z 800-1000, which include unresolved isobaric 
peaks from DBA, need no type II isotope correction to match target 
concentrations (illustrated in Figure 3.21); instead this correction may result in 
significant overcorrection. Importantly, only intensities picked in first and second 
case constellations should be considered as accurate but not those from a third 
case assignment. 
3.1 Isotope Correction Algorithm for FIA-FTMS 
[61] 
 
 
Figure 3.21 Resolvable m/z considering a 1×FWHM separation of two equal 
abundant species using a mass resolution setting of 140,000 (at m/z 200). The 
dashed line indicates the DBA difference of m/z 0.00894. In the mass range 
type II isotopic correction is not necessary for m/z < 600 and 800-1000.  I/A 
correction improves the accuracy in mass range m/z 600-800. 
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3.2 Quantification of Cholesterol and Cholesteryl Ester 
Quantification of FC and CE in biological samples like serum or lipoprotein 
fractions (Wiesner, Leidl, Boettcher, Schmitz, & Liebisch, 2009) needs to be 
accurate and reproducible to translate lipidomic tools finally to clinical 
applications (Burla et al., 2018; Holcapek, Liebisch, & Ekroos, 2018). The 
following chapters provide detailed insight in the quantification of FC by FIA-
MSX/FTMS and CE by FIA-FTMS. 
The annotation of FC and CE is based on the fact that cholesterol represents by 
far the most abundant sterol with 27 carbons and 1 DB (ST 27:1) in the 
investigated mammalian samples (Liebisch et al., 2013). In rare diseases of the 
cholesterol biosynthesis pathway like lathosterolosis the cholesterol isomers 
lathosterol and zymostenol may be present at higher level. In that case their 
identification needs chromatographic separation (Krakowiak et al., 2003). 
3.2.1 Quantification of Free Cholesterol by FIA-MSX/FTMS 
Direct quantification of FC was recently described using a chip-based direct 
infusion nano-ESI-MSX-FTMS/MS-based approach for human and murine 
plasma samples (Gallego, Hojlund, & Ejsing, 2017). Here, we evaluated 
whether direct quantification of FC is also feasible using FIA-ESI-MSX/FTMS 
with a quadrupole-Orbitrap instrument in human serum, human fibroblast cells 
and murine liver samples. As described by Gallego et al. (Gallego et al., 2017) 
ammoniated FC and CE undergo in-source fragmentation to yield a protonated 
cholestadiene fragment at m/z 369.3516. Therefore, the extent of in-source 
fragmentation was assessed in our setting by infusing neat analytical FC and 
CE 17:0 standards. The percentage of intact analyte was calculated out of the 
added intensities of the ammoniated species and the protonated cholestadiene 
fragment.  The experiment revealed significant differences in their susceptibility 
to in-source fragmentation: 27% of FC and 74% of CE 17:0 are unimpaired. 
To achieve accurate FC quantification, we took advantage from multiplexing 
(MSX) of analyte and internal standard pairs in PRM (Gallego et al., 2017; 
Liebisch & Matysik, 2015; Matysik & Liebisch, 2017; Schott et al., 2018). In an 
initial experiment, FC concentrations of human serum samples were determined 
by MSX/FTMS at mass resolution settings of 17,500 at m/z 200, and then 
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compared to our previously established method using FIA-MS/MS and an acetyl 
chloride derivatization on a triple quadrupole mass spectrometer (Liebisch et al., 
2006). FC concentrations determined by these methods did not sufficiently 
correlate, with markedly higher values observed by the MSX/FTMS method. 
Mass resolution of the method was increased, to evaluate whether an isobaric 
interference is present. Product ion spectra at increased mass resolution 
revealed an isobaric fragment ion at m/z 369.337 (Figure 3.22), which most 
likely derives from monoacylglycerol MG 20:0. FTMS analysis confirmed 
matching ions at m/z 404.3734 [M+NH4]
+ in positive and m/z 431.3378 
[M+HCOO]- in negative ion mode. In order to ensure an unambiguous 
differentiation of cholestadiene and the isobaric interference (mass difference of 
0.015 Da), we chose a mass resolution setting of 140,000 at m/z 200 providing 
baseline separation of both peaks.  
 
Figure 3.22 MSX/FTMS spectra of FC [M+NH4]
+ in human serum recorded at 
different resolutions. A series of spectra recorded in positive ion mode at mass 
resolution settings of 17,500, 35,000, 70,000, and 140,000 (at m/z 200) reveals 
isobaric ions of protonated cholestadiene and MG 20:0 [M+H-H2O]
+ (m/z 
0.015). 
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Despite the poor ionization and low signal intensity of FC [M+NH4]
+, we 
evaluated the accuracy of the high resolution MSX method. Therefore, we 
compared our acetyl chloride derivatization with direct MSX analysis in human 
serum, cultured cells, and murine liver samples. Of note, the derivatization 
increased the signal intensity of FC and D7-FC by ~400 fold. Nevertheless, all 
analyzed samples were in good agreement with in average 3-6% higher 
concentrations for the derivatized samples (Table 3.1) indicating that the direct 
analysis performs as well as the acetyl chloride derivatization method. 
Table 3.1 Comparison of FC analyzed directly or after performance of 
derivatization with acetyl chloride for human serum, cultured primary human 
fibroblast cells, and murine liver samples, measured by FIA-MSX/FTMS. 
 
Serum 
[µM] 
Cells 
[nmol/mg protein] 
Liver 
[nmol/mg wet weight] 
Sample Derivatization 
Direct 
Analysis 
Derivatization 
Direct 
Analysis 
Derivatization 
Direct 
Analysis 
1 951 834 53 50 4.3 4.1 
2 1136 1076 62 61 4.6 4.1 
3 1199 1092 56 55 4.5 4.4 
4 1456 1284 71 69 4.6 4.2 
5 1591 1595 48 50 6.4 6.0 
6 1437 1380 43 44 3.4 3.4 
7 1038 1065 54 54 3.6 3.6 
8 1646 1568 
  
4.3 4.4 
9 888 873 
  
2.6 2.8 
 
3.2.2 Analytical Response of Cholesteryl Esters quantified by 
FIA-ESI-FTMS 
Cholesterol is mainly stored or transported as CE, which is one of the most 
abundant lipid classes in human plasma (Burla et al., 2018; Sales et al., 2016). 
In laboratory testing, the amount of cholesterol is determined as total 
cholesterol (TC equals esterified and non-esterified) with enzymatic tests 
certified for clinical diagnostic. In an initial experiment, we compared TC 
concentrations of 18 human serum samples determined by MSX/FTMS for FC 
and FTMS for CE with the enzymatically determined values (mean TC 
concentration was 5.17 ± 2.56 mM). MS and enzymatically derived TC 
concentrations showed a good correlation but MS values were about 50% 
higher (Figure 3.23). Since previous studies indicated that lipid species 
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response may be influenced by length and unsaturation degree of the acyl 
chains (Brugger, Erben, Sandhoff, Wieland, & Lehmann, 1997; Cullen et al., 
1997; Hutchins, Barkley, & Murphy, 2008; Koivusalo, Haimi, Heikinheimo, 
Kostiainen, & Somerharju, 2001; Liebisch et al., 2006), we investigated the 
analytical response of CE species in detail.  
 
Figure 3.23 Correlation of total cholesterol determined enzymatically and by 
FIA-FTMS and FIA-MSX/FTMS. A total of n=18 human serum samples were 
analyzed.  
 
3.2.2.1 Effect of Acyl Chain Composition and Ionization Adduct 
To study these effects, a standard mixture containing five saturated and five 
unsaturated CE species was compiled, analyzed by FTMS, and their response 
determined as specified in the experimental section (2.7 Instrument Response 
of Cholesteryl Esters). Two things are apparent from analysis of NH4-adducts – 
the instrument response of saturated and monounsaturated species increases 
linearly with the acyl chain length (Figure 3.24A). Notably, however, the acyl 
chain unsaturation has a significantly higher influence on the response, which 
also increases systematically with double-bond count (Figure 3.24A, inset).  
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Figure 3.24 Effect of acyl chain length and degree of unsaturation on CE 
species response. The figure shows the determined response of (A) NH4-
adducts and (B) Na-adducts. The response of saturated (blue), 
monounsaturated (orange), and polyunsaturated (grey) species is plotted 
against the acyl chain length. Total CE concentration is 9.41 pmol/µL. The inset 
displays the response of C18-CE species plotted against the number of double 
bonds. The response was calculated as the molar ratio of detected to expected 
quantities. Displayed are mean ± SD of three independent experiments. 
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On the basis of these data, we expect a linear dependency for increasing acyl 
chain lengths for each series of polyenoic CE species, with a slope similar to 
that of the saturated and monounsaturated species. Due to a limited number of 
polyunsaturated CE species commercially available we could not test their 
response in detail. The chosen TC concentration of 9.41 pmol/µL (in vial) is 
corresponding to 5.44 mM (comparable to serum concentrations), and 
resembles the mean TC concentration of the 18 human serum samples 
determined enzymatically with 5.17 ± 2.56 mM. 
Considerable use has been made of the positive charged ammonium adduct for 
analysis of CE (Liebisch et al., 2006). To gain further information on CE 
response behavior, corresponding response experiments have been performed 
with the alkali metal ion adduct [M+Na]+ (Figure 3.24B). The trends observed 
are similar; however, the impact of acyl chain length and DB number on the 
species specific response is lower. The response increases for the NH4-adduct 
with a linear slope of 0.57 and for the Na-adduct with 0.214.  
Collisional activation of [M+NH4]
+ results in the formation of the characteristic 
cholestadiene ion of m/z 369. This product ion is the result of an initial hydrogen 
rearrangement, so that the resulting carbon-centered cationic site, following the 
loss of H2O and NH3, can be delocalized over the adjacent double bond 
(Murphy, 2015). As already mentioned, it has been shown that CE species 
[M+NH4]
+ undergo in-source fragmentation producing the specific fragment ion 
of m/z 369 during electrospray. Therefore, we asked whether the observed 
response effect may be caused by in-source fragmentation during electrospray 
ionization. Individual CE species were analyzed by FTMS, and the percentage 
of intact ions was calculated out of the added intensities of precursor [M+NH4]
+ 
and the protonated cholestadiene fragment (Figure 3.25). The figure 
demonstrates that species stability increases with the acyl chain length as well 
as with the degree of unsaturation. The similarity to the observed response 
effects (Figure 3.24) indicates that the in-source fragmentation is a main cause 
for response differences of CE species. The presence of double bonds in the 
acyl chain substantially decreases the susceptibility of [CE+NH4]
+ ions to 
undergo in-source fragmentation, signifying a pronounced charge stabilizing 
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effect. Analogous explanation can be applied for the stabilization effect induced 
by chain length, although to a slightly lower extent compared to DB.  
Sodiated ions [M+Na]+ displayed different fragmentation characteristics 
compared to ammoniated (CE 17:0 and CE 22:0 product ion spectra of 
[M+NH4]
+ and [M+Na]+ are displayed in Figure 3.26). While at 20% HCD 
ammoniated precursor ions [M+NH4]
+ are completely fragmented to 
cholestadiene ions of m/z 369, [M+Na]+ ions did only partially fragment as 
CE 17:0 and CE 22:0 at m/z 661.589 and 731.668 represent the most intense 
ions, respectively. Moreover, sodiated ions form the acyl chain fragments at m/z 
293.245 for fatty acid 17:0 and m/z 363.323 for fatty acid 22:0. This clearly 
indicates an increased stability of Na-adducts that might be related also to their 
less pronounced response effects (Figure 3.24). 
 
Figure 3.25 In-source fragmentation of CE species. Each CE species was 
analyzed separately by FIA-FTMS. Displayed is the percentage of intact 
precursor [M+NH4]
+ against the number of carbons of the acyl chain. 
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Figure 3.26 Comparison of FTMS/MS spectra of CE 17:0 and CE 22:0 
analyzed as [M+NH4]
+ and [M+Na]+. Spectra have been recorded at 20% HCD 
in positive ion mode. 
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3.2.2.2 Effect of Total CE Concentration 
Previous mass spectrometric studies indicate that lipid concentration of the 
infusate may influence analytical response (Koivusalo et al., 2001; Yang & Han, 
2011). To investigate the influence of CE concentration on the response, the 
mixture of CE standards was measured at 11 concentrations ranging from ~1.7 
to 23.6 pmol/µL in the infusate. While the response of saturated and 
monounsaturated CE species remained constant within the concentration range 
of interest, a pronounced increase was observed for polyunsaturated species, in 
particular for CE 18:3 (Figure 3.27). This indicates that at high sample 
concentrations the polyunsaturated CE species are markedly overrepresented. 
Of note, the concentrations applied here fit very well to previously described 
recommendations for lipid concentrations of infusates in shotgun mass 
spectrometry (Koivusalo et al., 2001; Yang & Han, 2011). 
 
Figure 3.27 Effect of total CE concentration on CE species response. 
CE species are plotted against the total CE concentration of the injected 
standard mix. Displayed are mean ± SD of three independent experiments. 
To check if this effect also derives from different in-source species stability, we 
monitored the amount of in-source fragmentation of C18-CE species in a 
dilution series within a spike range of approximate 1000-folds of magnitude 
(Figure 3.28). Nonetheless, concentration had only negligible effects on the 
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susceptibility to undergo in-source fragmentation. Hence, a potential 
explanation could be that aggregation of highly hydrophobic CE at higher 
concentrations results in less efficient ionization. Notably, the introduction of 
double bonds influences species polarity/polarity-distribution, as well as the acyl 
chain structure. Here, it has to be considered that the response was calculated 
using the CE 17:0 as internal standard, which explains that relative response of 
saturated species is not influenced by concentration effects since they have a 
similar polarity and structure and aggregate in a similar way, accordingly. 
Unexpectedly, monounsaturated CE species seem to behave like saturated 
species in this respect. Polyunsaturated CE species, however, appear to be 
less susceptible to aggregation resulting in an increased relative response due 
to enhanced aggregation of the saturated internal standard. To accurately 
compensate for this effect, spike-in of unsaturated CE internal standards could 
be advantageous.  
 
Figure 3.28 Effect of concentration on the in-source fragmentation. Each C18-
CE species was analyzed separately by FIA-FTMS. Displayed is the percentage 
of intact precursor [M+NH4]
+ against the concentration in the infusate. 
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3.2.2.3 Influence of Sample Matrix  
Typically, biological samples comprise a complex mixture of different lipid 
classes and species. Therefore, we asked how responses of CE lipids are 
influenced by addition of triacylglycerols (TG) and phosphatidylcholines (PC), 
representing the other main components of human serum. To a constant 
concentration of the CE standard mixture, we spiked in either a mix of different 
TG, PC, or both, in concentrations resembling the physiological range for these 
lipid classes, and analyzed those samples by FIA-FTMS. The composition and 
concentration of the defined mixtures is described in chapter 2.7.1 Preparation 
of Standard Mixtures and Matrix Spikes. Inclusion of TG and PC reduced the 
response of CE species to a similar extent and this effect was more pronounced 
for polyunsaturated species (Figure 3.29). Simultaneous addition of both, TG 
and PC, showed an additional response reduction, again more pronounced for 
polyunsaturated species. The response was reduced to 95% for CE 18:0, to 
91% for CE 18:1, and to 89% for CE 18:2 and CE 18:3. The chain length had 
only a neglectable influence on the response reduction (data not shown). 
 
Figure 3.29 Response changes induced by addition of TG and/or PC. The 
responses of the C18-CE species of the CE mixture with a total cholesterol 
concentration of 9.41 pmol/µL were analyzed in the presence of a PC mixture 
(total PC concentration of 5.8 pmol/µL), TG mixture (total TG concentration of 
5.4 pmol/µL), and both lipid class mixtures together. Addition of TG and PC 
shows mean ± SD of two technical replicates. 
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We checked for the in-source fragmentation of C18-CE species in presence of 
TG and/or PC but could not detect any changes (Figure 3.30). Potentially, the 
presence of other lipid classes influences aggregation of CE species. 
 
Figure 3.30 Influence of TG and/or PC on the in-source fragmentation. Each 
C18-CE species was analyzed separately by FIA-FTMS.  
 
3.2.2.4 Quantification of CE Species in a Dilution Series of Human 
Serum 
To further understand the influence of sample concentration on CE species 
response, we selected three patient serum samples differing in their TC and 
total TG concentrations: patient #1 with high TC (8.74 mM) and low TG 
(1.48 mM), patient #2 with high TC (8.84 mM) and high TG (3.66 mM), and 
patient #3 with low TC (4.58 mM) and low TG (2.09 mM). The reference levels 
were determined by enzymatic testing. The samples were extracted, diluted 
sequentially (by a factor of two) up to a 132-fold dilution, and finally analyzed by 
FIA-FTMS and FIA-MSX/FTMS. The dilution effect was calculated from the non-
diluted related to the mean concentration of 16-fold dilution. Total CE 
concentration decreased to 86% for both high TC samples and to 90% for the 
low TC sample (Table 3.2), and as expected, dilution effects were most 
pronounced for polyunsaturated (PUFA) CE species confirming our results 
obtained with synthetic standard mixtures. In addition, dilution effects for both 
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high TC samples (patient #1 and #2) were almost identical, even though their 
TG level is diverging. This argues for a minor influence of TG compared to TC 
concentration on CE species response (total lipid concentration vs lipid class 
concentration). Moreover, dilutions of more than 8-fold did not result in a further 
decrease of total CE and PUFA CE species concentrations. Saturated CE 
species and free cholesterol were not influenced by sample dilution, and 
monounsaturated (MUFA) CE species only slightly. However, in dilutions of 16-
fold and higher signals of FC were below the LOD. Therefore, the FC 
concentration measured at 8-fold dilution was used to calculate TC for further 
dilution steps. Notably, also for most diluted samples total cholesterol 
concentrations determined by FTMS and MSX/FTMS were about 30% higher 
than those analyzed enzymatically. Hence, an accurate quantification of CE 
species by FTMS requires application of species-specific response factors even 
in diluted samples. Remarkably, when these samples were subjected to 
analysis of additional lipid classes, we observed that dilution of more than 4-fold 
reduced signals of some low-abundant lipid species below the limit of detection 
(LOD) due to a relative increase of ions of the chemical background. For 
example LPC 20:4 could be quantified up to 32-fold dilution with a CV of <13% 
and fell under the LOD after further dilution. Other examples were Cer 42:1;2, 
PE 34:1, PI 38:4 et cetera. Since those lipid species have been shown to be 
relevant in previous studies (Drobnik et al., 2003; Heimerl et al., 2014; Peng et 
al., 2018; Sigruener et al., 2014), we chose to omit further sample dilution and 
to consider the concentration effect within the detected species-specific 
response.  
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Table 3.2 Dilution effect on CE concentrations quantified in three human serum 
samples by FIA-FTMS. Each value represents n=3 technical replicates. 
    x-fold dilution 1 2 4 8 16 32 64 132 Dilution Effect 
TC 
#1 mM 13.7 13.3 12.8 12.4 12.2 12.1 12.3 12.4 89% 
#2 mM 13.9 13.3 12.9 12.8 12.3 12.4 12.3 12.5 89% 
#3 mM 6.9 6.9 6.6 6.5 6.4 6.4 6.5 6.5 92% 
Total 
CE 
#1 mM 11.1 10.7 10.1 9.8 9.5 9.5 9.7 9.7 86% 
#2 mM 11.5 10.9 10.6 10.4 9.9 10.0 9.9 10.2 86% 
#3 mM 5.5 5.4 5.1 5.1 4.9 4.9 5.0 5.1 90% 
CE 
22:6 
#1 
µM 117 107 97 89 86 82 83 83 74% 
% of total 1.1% 1.0% 1.0% 0.9% 0.9% 0.9% 0.9% 0.8%   
#2 
µM 109 100 95 85 81 79 78 78 74% 
% of total 0.9% 0.9% 0.9% 0.8% 0.8% 0.8% 0.8% 0.8%   
#3 
µM 74 70 63 61 59 59 58 59 80% 
% of total 1.4% 1.3% 1.2% 1.2% 1.2% 1.2% 1.2% 1.2% 
 
CE 
20:5 
#1 
µM 260 243 218 206 194 193 202 201 74% 
% of total 2.4% 2.3% 2.1% 2.1% 2.0% 2.0% 2.1% 2.1%   
#2 
µM 160 144 135 129 118 119 118 121 74% 
% of total 1.4% 1.3% 1.3% 1.2% 1.2% 1.2% 1.2% 1.2%   
#3 
µM 84 82 74 71 68 67 70 69 81% 
% of total 1.5% 1.5% 1.4% 1.4% 1.4% 1.4% 1.4% 1.3% 
 
CE 
20:4 
#1 
mM 0.99 0.94 0.89 0.83 0.79 0.80 0.83 0.82 79% 
% of total 9.0% 8.8% 8.7% 8.5% 8.3% 8.5% 8.6% 8.5%   
#2 
mM 1.07 0.99 0.94 0.92 0.84 0.86 0.85 0.88 79% 
% of total 9.3% 9.0% 8.9% 8.8% 8.5% 8.6% 8.6% 8.6%   
#3 
mM 0.91 0.91 0.82 0.82 0.77 0.77 0.80 0.80 85% 
% of total 16.6% 16.8% 16.0% 16.1% 15.6% 15.6% 15.9% 15.7%   
CE 
18:3 
#1 
µM 448 423 393 372 354 348 355 358 79% 
% of total 4.0% 4.0% 3.9% 3.8% 3.7% 3.7% 3.7% 3.7%   
#2 
µM 298 278 266 253 237 234 230 240 79% 
% of total 2.6% 2.5% 2.5% 2.4% 2.4% 2.3% 2.3% 2.4%   
#3 
µM 113 113 103 98 97 96 98 99 85% 
% of total 2.1% 2.1% 2.0% 1.9% 2.0% 1.9% 1.9% 2.0%   
CE 
18:2 
#1 
mM 5.78 5.53 5.20 4.97 4.84 4.77 4.86 4.94 84% 
% of total 52.3% 51.8% 51.3% 50.8% 50.8% 50.5% 50.2% 50.7%   
#2 
mM 5.97 5.61 5.41 5.27 5.01 5.03 4.96 5.15 84% 
% of total 52.0% 51.5% 51.3% 50.6% 50.5% 50.4% 50.2% 50.6%   
#3 
mM 2.58 2.53 2.39 2.32 2.27 2.26 2.32 2.33 88% 
% of total 47.1% 46.5% 46.4% 45.8% 45.9% 45.9% 46.0% 45.8% 
 
CE 
18:1 
#1 
mM 1.94 1.92 1.86 1.84 1.82 1.81 1.83 1.81 94% 
% of total 17.5% 18.0% 18.3% 18.8% 19.1% 19.1% 18.9% 18.6%   
#2 
mM 2.14 2.08 2.03 2.07 2.00 2.02 1.98 2.00 93% 
% of total 18.6% 19.1% 19.2% 19.8% 20.2% 20.2% 20.1% 19.6%   
#3 
mM 0.91 0.92 0.91 0.91 0.89 0.88 0.88 0.88 98% 
% of total 16.7% 17.0% 17.6% 18.0% 18.1% 17.9% 17.4% 17.3%   
CE 
16:0 
#1 
mM 0.78 0.78 0.77 0.77 0.76 0.78 0.81 0.82 97% 
% of total 7.1% 7.3% 7.6% 7.9% 8.0% 8.2% 8.4% 8.4%   
#2 
mM 0.94 0.91 0.90 0.93 0.90 0.91 0.92 0.95 96% 
% of total 8.2% 8.3% 8.5% 9.0% 9.0% 9.1% 9.3% 9.3%   
#3 
mM 0.46 0.46 0.46 0.46 0.46 0.47 0.48 0.50 101% 
% of total 8.4% 8.5% 8.9% 9.1% 9.4% 9.5% 9.5% 9.9%   
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3.2.2.5 Model Compilation for calculating Species-specific 
Responses 
The experimentally gathered information about CE response behavior including 
acyl chain composition, in-source fragmentation, sample concentration, and 
addition of TG and PC have been used to compile a model to calculate species-
specific response factors for biological samples, especially adapted for serum 
and plasma samples. First, the number of carbon atoms of the acyl chain 
increased the response linearly and the slope of that increase seems to be 
independent of the number of DB.  Therefore, we used the mean of the 
regression line slopes of saturated and MUFA CE species to include the linear 
carbon dependency in our model (C is the number of carbons): 
𝑟𝑒𝑠𝑝𝑜𝑛𝑠𝑒 (𝑐𝑎𝑙𝑐𝑑) = 0.049 ∗ 𝐶 
Second, we demonstrated a linear relationship of response to the number of DB 
of the acyl chain (Figure 3.24A, inset). Chain length and DB dependency were 
compiled additively for response calculation (DB is the number of double 
bonds): 
𝑟𝑒𝑠𝑝𝑜𝑛𝑠𝑒 (𝑐𝑎𝑙𝑐𝑑) = 0.049 ∗ 𝐶 + 0.57 ∗ 𝐷𝐵 
The fact that CE species response was influenced by the total CE concentration 
was included by analyzing the carbon and DB dependency at physiological TC 
concentrations of human serum samples. Third, species response was affected 
by the addition of other lipid components. This matrix factor was derived from 
changes in response upon addition of TG and PC (Figure 3.29). The 
determined factor was 0.95 for CE 18:0, 0.91 for CE 18:1, and 0.89 for CE 18:2 
and CE 18:3. For response calculation, the factor of the species with the 
corresponding number of DB was applied. For species with a higher degree of 
unsaturation, the matrix factor of 0.89 was used since it reached saturation after 
two DB (A is the matrix factor): 
𝑟𝑒𝑠𝑝𝑜𝑛𝑠𝑒(𝑐𝑎𝑙𝑐𝑑) = [0.049 ∗ 𝐶 + 0.57 ∗ 𝐷𝐵] ∗ 𝐴 
To simplify the application of response correction, the calculated response was 
converted into a factor, which seems to be more consistent with already 
published literature (Chen, Green, & Nichols, 2013; Han & Gross, 2001; 
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Koivusalo et al., 2001). Measured CE concentrations were multiplied by the 
calculated species-specific response factors: 
𝑟𝑒𝑠𝑝𝑜𝑛𝑠𝑒 𝑓𝑎𝑐𝑡𝑜𝑟 =
1
[0.049 ∗ 𝐶 + 0.57 ∗ 𝐷𝐵] ∗ 𝐴
 
 
3.2.2.6 Application of Response Correction on Human Serum 
Samples 
The response calculation model was applied to calculate the species-specific 
response factors of CE determined in human serum samples (Table 3.3). These 
factors have been used to correct CE concentrations of the 18 human serum 
samples of our initially performed experiments (Figure 3.31). FTMS and 
MSX/FTMS derived TC concentrations were in good agreement after correction 
of the individual CE response arguing that accurate quantification of CE by 
FTMS needs implementation of CE species-specific response factors.  
Table 3.3 Species-specific response factors of CE species determined for 
human serum/plasma samples.  
Species 
C-atoms 
(=C) 
Double  
Bonds (=DB) 
Matrix Factor  
(=A) 
Response factor 
CE only 
a
 
Response factor 
b
 
CE 14:0 14 0 0.95 1.46 1.53 
CE 15:0 15 0 0.95 1.36 1.43 
CE 16:1 16 1 0.91 0.74 0.81 
CE 16:0 16 0 0.95 1.27 1.34 
CE 17:1 17 1 0.91 0.71 0.78 
CE 18:3 18 3 0.89 0.39 0.43 
CE 18:2 18 2 0.89 0.49 0.56 
CE 18:1 18 1 0.91 0.69 0.75 
CE 20:5 20 5 0.89 0.26 0.29 
CE 20:4 20 4 0.89 0.31 0.34 
CE 22:6 22 6 0.89 0.22 0.25 
CE 22:4 22 4 0.89 0.30 0.33 
a
 Response factor = 1 / (0.049 ∗ C + 0.57 ∗ DB) 
b
 Response factor = 1 / [(0.049 ∗ C + 0.57 ∗ DB) ∗ A] 
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Figure 3.31 Correlation of total cholesterol determined enzymatically and by 
FIA-FTMS and FIA-MSX/FTMS. Response correction was applied for all 
detected CE species. A total of n=18 human serum samples were analyzed. 
 
3.2.2.7 Response Comparison with Chip-based Infusion nano ESI-
FTMS 
The described response effects were observed using FIA with a conventional 
LC system coupled to a Q Exactive Orbitrap high resolution FTMS instrument. 
Another question was whether such response differences are limited to 
conventional ESI. Therefore, we analyzed the CE mixture samples as 
[CE+NH4]
+ by chip-based nano-ESI coupled to an Orbitrap Fusion (Figure 3.32) 
in collaboration with Prof. Christer Ejsing’s labs. The linear increase of response 
with DB count matched very well the results obtained by conventional ESI 
(Figure 3.24A). The trend for the acyl chain length appears similar; however, it 
does not seem to follow a linear trend at higher carbon numbers. In addition, the 
response was increasing with the TC concentration and this effect was more 
pronounced for PUFA species (Figure 3.32B). The response of saturated 
species was not influenced within the TC concentration range. Possible 
explanation might be again lipid aggregation that results in less efficient 
ionization of highly hydrophobic CE species. The quantification was performed 
with the saturated internal standard CE 17:0 that should aggregate alike the 
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analyzed saturated CE species. The concentration effect observed by nano-ESI 
resembles the data recorded with our conventional LC pump system (Figure 
3.27), although the effect was slightly higher on our setup.  
 
Figure 3.32 CE species response measured on an Orbitrap Fusion using nano-
ESI. Panel A shows the effect of acyl chain length and degree of unsaturation 
(TC concentration was 9.41 pmol/µL). The insert illustrates the response of 
C18-CE species plotted against the number of double bonds. Panel B displays 
the effect of total CE concentration on C18-CE species response.  
Nonetheless, the comparison of ESI and nano-ESI demonstrated that the 
marked effect of DB number is not limited to conventional ESI. Remarkably, the 
response trends observed for both ion sources were similar despite strongly 
disparate flow rates of 200 nL/min and 10 µL/min for nano-ESI and ESI, 
respectively. This indicates that the correction of response should be 
considered for different systems and that the mathematical model for calculation 
of CE species-specific response factors may be applicable in different 
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instrument setups. However, such models should be adjusted and validated for 
the individual setup.  
3.3 Method Validation 
[81] 
3.3 Method Validation 
The biological samples have been measured and analyzed by FIA-FTMS as 
described in the experimental section (2.6 Lipid Species Quantification by FIA-
FTMS). 
3.3.1 Intraday and Day-to-Day Reproducibility 
The reproducibility was determined for CE, FC (MSX/FTMS), DG, TG, Cer, 
LPC, LPE, PC, PC O-, PE, PE O-, PG, and PI (see Table 3.4 - Table 3.11). 
Intraday CV’s were generally < 5% for all analyzed species. For day-to-day 
precision, the CV’s were slightly higher, but for the majority of species still below 
15%. These findings demonstrate that the workflow including extraction, FIA-
FTMS analysis, and data evaluation delivers reproducible concentrations. Even 
the analysis of samples within a four-month time interval (day-to-day 
reproducibility) confirms the high reproducibility over time.  
The mean concentrations determined for intraday and day-to-day precision 
matched very well for most lipid classes. However, concentrations of DG in the 
day-to-day experiments (Table 3.5) were slightly higher and those of TG (Table 
3.6) slightly lower compared to the intraday concentrations. A possible 
explanation for this shift could be sample instability related to activity of lipases 
during freeze and thaw cycles. These enzymes may hydrolyze TG to DG that 
can be further degraded to MG.  
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Table 3.4 Coefficient of variation (CV) of intraday and day-to-day precision of CE species and FC determined in human serum, 
human fibroblast cell homogenates, and murine liver samples by FIA-FTMS and FIA-MSX/FTMS. CE species [M+NH4]
+ have been 
corrected for their response. 
  
Human serum 
 
Human fibroblast cells 
 
Murine liver 
  
Intraday precision Day-to-day precision 
 
Intraday precision Day-to-day precision 
 
Intraday precision Day-to-day precision 
Species   
Mean  
n=5 
[nmol/mL] 
CV 
Mean  
n=5 
[nmol/mL] 
CV   
Mean  
n=5 
[nmol/mg 
protein] 
CV 
Mean  
n=5 
[nmol/mg 
protein] 
CV   
Mean  
n=5 
[nmol/mg 
wet weight] 
CV 
Mean  
n=5 
[nmol/mg 
wet weight] 
CV 
CE 14:0 
 
46 1% 48 8% 
          CE 15:0 
 
14 5% 14 8% 
          CE 16:1 
 
121 2% 125 6% 
 
0.18 17% 0.19 15% 
     CE 16:0 
 
544 2% 570 8% 
 
0.63 23% 0.64 24% 
 
0.033 5% 0.032 9% 
CE 17:1 
 
18 3% 21 11% 
 
0.14 3% 0.15 9% 
     CE 18:3 
 
61 2% 60 7% 
          CE 18:2 
 
1853 2% 1851 7% 
          CE 18:1 
 
681 1% 705 6% 
 
1.4 6% 1.5 8% 
 
0.025 6% 0.026 9% 
CE 20:5 
 
29 2% 28 9% 
          CE 20:4 
 
195 3% 186 9% 
          CE 22:6 
 
13 2% 11 12% 
          CE 22:1 
      
0.19 4% 0.21 1% 
     FC   1121 3% 1179 11%   59 3% 57 9%   4.2 2% 4.1 11% 
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Table 3.5 CV of intraday and day-to-day precision of DG species determined as [M+NH4]
+ in human serum, human fibroblast cell 
homogenates, and murine liver samples by FIA-FTMS.  
  
Human serum 
 
Human fibroblast cells 
 
Murine liver 
  
Intraday precision Day-to-day precision 
 
Intraday precision Day-to-day precision 
 
Intraday precision Day-to-day precision 
Species   
Mean  
n=5 
[nmol/mL] 
CV 
Mean  
n=5 
[nmol/mL] 
CV   
Mean  
n=5 
[nmol/mg 
protein] 
CV 
Mean  
n=5 
[nmol/mg 
protein] 
CV   
Mean  
n=5 
[nmol/mg 
wet weight] 
CV 
Mean  
n=5 
[nmol/mg 
wet weight] 
CV 
DG 32:2 
      
0.11 9% 0.12 12% 
 
0.0085 12% 0.0083 16% 
DG 32:1 
 
1.9 16% 2.0 17% 
 
0.46 5% 0.46 4% 
 
0.089 4% 0.093 3% 
DG 32:0 
           
0.11 6% 0.11 12% 
DG 34:2 
 
4.1 6% 4.5 8% 
 
0.55 3% 0.55 5% 
 
0.13 1% 0.12 5% 
DG 34:1 
 
7.7 16% 8.0 11% 
 
1.3 8% 1.2 7% 
 
0.19 2% 0.20 3% 
DG 36:4 
 
5.2 27% 5.1 13% 
          DG 36:3 
 
7.4 4% 8.5 9% 
 
0.21 9% 0.21 5% 
 
0.035 4% 0.034 15% 
DG 36:2 
 
8.9 4% 10.1 10% 
 
0.96 3% 1.0 3% 
 
0.11 3% 0.11 4% 
DG 36:1 
      
0.56 11% 0.54 11% 
 
0.038 2% 0.041 8% 
DG 36:0 
      
1.8 6% 1.8 3% 
     DG 38:4 
           
0.091 3% 0.080 13% 
DG 38:3 
      
0.16 5% 0.18 4% 
 
0.013 7% 0.013 15% 
DG 38:2             0.18 5% 0.20 7%           
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Table 3.6 CV of intraday and day-to-day precision of TG species determined as [M+NH4]
+ in human serum, human fibroblast cell 
homogenates, and murine liver samples by FIA-FTMS. 
  
Human serum 
 
Human fibroblast cells 
 
Murine liver 
  
Intraday precision Day-to-day precision 
 
Intraday precision Day-to-day precision 
 
Intraday precision Day-to-day precision 
Species   
Mean  
n=5 
[nmol/mL] 
CV 
Mean  
n=5 
[nmol/mL] 
CV   
Mean  
n=5 
[nmol/mg 
protein] 
CV 
Mean  
n=5 
[nmol/mg 
protein] 
CV   
Mean  
n=5 
[nmol/mg 
wet weight] 
CV 
Mean  
n=5 
[nmol/mg 
wet weight] 
CV 
TG 40:3 
      
0.14 6% 0.14 6% 
 
0.015 5% 0.014 8% 
TG 40:1 
 
2.9 2% 2.9 4% 
      
0.0067 7% 0.0063 3% 
TG 40:0 
 
4.7 3% 4.6 3% 
          TG 42:2 
 
2.0 3% 1.9 5% 
          TG 42:1 
 
5.8 4% 5.8 6% 
          TG 42:0 
 
8.1 1% 7.9 5% 
          TG 44:3 
 
1.4 3% 1.2 6% 
          TG 44:2 
 
5.3 2% 5.1 6% 
          TG 44:1 
 
13 2% 13 3% 
 
0.16 4% 0.15 5% 
 
0.0067 6% 0.0062 8% 
TG 44:0 
 
13 1% 12 7% 
 
0.098 9% 0.10 10% 
 
0.0060 5% 0.0059 13% 
TG 45:1 
 
2.2 5% 2.1 6% 
          TG 46:3 
 
3.4 5% 3.3 6% 
 
0.091 5% 0.090 7% 
     TG 46:2 
 
12 3% 11 5% 
 
0.31 3% 0.30 5% 
 
0.019 5% 0.017 12% 
TG 46:1 
 
26 2% 25 8% 
 
0.48 2% 0.46 5% 
 
0.044 3% 0.041 5% 
TG 46:0 
 
20 2% 20 7% 
 
0.23 5% 0.23 11% 
 
0.037 2% 0.037 4% 
TG 47:2 
 
2.0 4% 1.8 4% 
          TG 47:1 
 
5.1 2% 4.9 6% 
          TG 47:0 
 
4.6 3% 4.4 6% 
          TG 48:4 
 
8.5 2% 8.2 8% 
 
0.50 3% 0.49 9% 
 
0.058 5% 0.055 10% 
TG 48:3 
 
13 2% 12 7% 
 
0.31 3% 0.29 5% 
 
0.021 3% 0.016 18% 
TG 48:2 
 
36 2% 36 5% 
 
1.0 3% 1.0 4% 
 
0.16 3% 0.14 11% 
TG 48:1 
 
60 2% 60 4% 
 
1.2 2% 1.2 4% 
 
0.23 3% 0.23 5% 
TG 48:0   27 1% 27 7%   0.34 5% 0.34 7%   0.14 4% 0.14 4% 
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Human serum 
 
Human fibroblast cells 
 
Murine liver 
  
Intraday precision Day-to-day precision 
 
Intraday precision Day-to-day precision 
 
Intraday precision Day-to-day precision 
Species   
Mean  
n=5 
[nmol/mL] 
CV 
Mean  
n=5 
[nmol/mL] 
CV   
Mean  
n=5 
[nmol/mg 
protein] 
CV 
Mean  
n=5 
[nmol/mg 
protein] 
CV   
Mean  
n=5 
[nmol/mg 
wet weight] 
CV 
Mean  
n=5 
[nmol/mg 
wet weight] 
CV 
TG 49:2 
 
6.6 2% 6.4 6% 
 
0.13 5% 0.12 7% 
 
0.012 4% 0.010 15% 
TG 49:1 
 
12 1% 11 6% 
 
0.13 6% 0.13 7% 
 
0.012 5% 0.011 6% 
TG 49:0 
 
3.6 3% 3.6 8% 
          TG 50:5 
 
4.1 2% 3.7 5% 
 
0.10 2% 0.10 8% 
     TG 50:4 
 
16 2% 15 8% 
 
0.16 3% 0.15 6% 
     TG 50:3 
 
55 2% 52 7% 
 
1.2 2% 1.2 4% 
 
0.25 3% 0.19 19% 
TG 50:2 
 
121 2% 117 8% 
 
2.9 2% 2.8 4% 
 
0.80 3% 0.68 10% 
TG 50:1 
 
112 2% 113 5% 
 
1.9 2% 1.9 4% 
 
0.57 3% 0.55 5% 
TG 51:4 
 
3.6 3% 3.4 4% 
          TG 51:3 
 
8.4 3% 8.1 4% 
 
0.11 5% 0.11 5% 
 
0.011 4% 0.0095 20% 
TG 51:2 
 
14 2% 14 6% 
 
0.28 2% 0.27 6% 
 
0.022 2% 0.020 10% 
TG 51:1 
 
8.6 2% 8.7 3% 
 
0.14 3% 0.14 10% 
 
0.011 4% 0.010 5% 
TG 52:6 
 
6.2 2% 5.5 11% 
          TG 52:5 
 
28 1% 26 8% 
 
0.11 3% 0.11 6% 
     TG 52:4 
 
120 1% 112 7% 
 
1.1 8% 1.2 12% 
 
0.27 4% 0.17 31% 
TG 52:3 
 
283 1% 275 5% 
 
3.2 2% 3.1 2% 
 
0.85 3% 0.66 19% 
TG 52:2 
 
302 2% 300 6% 
 
4.7 1% 4.6 2% 
 
0.79 3% 0.72 8% 
TG 52:1 
      
1.1 2% 1.1 4% 
 
0.15 3% 0.14 3% 
TG 53:5 
 
3.6 3% 3.5 6% 
          TG 53:4 
 
4.7 3% 4.4 6% 
          TG 53:3 
 
8.2 3% 8.0 3% 
 
0.22 3% 0.22 4% 
     TG 53:2 
 
8.4 3% 8.2 8% 
 
0.28 2% 0.28 3% 
 
0.014 2% 0.012 13% 
TG 53:1   2.5 3% 2.5 6%   0.073 5% 0.067 12%           
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Human serum 
 
Human fibroblast cells 
 
Murine liver 
  
Intraday precision Day-to-day precision 
 
Intraday precision Day-to-day precision 
 
Intraday precision Day-to-day precision 
Species   
Mean  
n=5 
[nmol/mL] 
CV 
Mean  
n=5 
[nmol/mL] 
CV   
Mean  
n=5 
[nmol/mg 
protein] 
CV 
Mean  
n=5 
[nmol/mg 
protein] 
CV   
Mean  
n=5 
[nmol/mg 
wet weight] 
CV 
Mean  
n=5 
[nmol/mg 
wet weight] 
CV 
TG 54:7 
 
8.6 1% 7.2 16% 
          TG 54:6 
 
28 2% 24 12% 
 
0.14 4% 0.14 4% 
     TG 54:5 
 
54 2% 50 9% 
 
0.32 2% 0.32 6% 
     TG 54:4 
 
75 2% 71 7% 
 
1.09 2% 1.04 3% 
 
0.11 3% 0.091 19% 
TG 54:3 
 
78 1% 75 8% 
 
4.24 2% 4.09 6% 
 
0.30 3% 0.24 12% 
TG 54:2 
 
30 2% 29 8% 
 
2.15 2% 2.06 5% 
 
0.14 3% 0.12 6% 
TG 54:1 
 
7.1 4% 6.6 9% 
          TG 55:3 
      
0.19 3% 0.19 3% 
     TG 55:2 
      
0.10 7% 0.10 10% 
     TG 56:8 
 
9.3 2% 7.7 20% 
          TG 56:7 
 
23 1% 19 17% 
          TG 56:6 
 
25 3% 22 10% 
 
0.27 3% 0.27 3% 
     TG 56:5 
 
16 1% 15 11% 
 
0.45 2% 0.43 2% 
     TG 56:4 
 
4.1 5% 3.5 17% 
 
0.74 1% 0.72 6% 
     TG 56:3 
      
1.3 2% 1.3 3% 
     TG 56:2 
 
3.4 7% 2.7 20% 
 
0.56 2% 0.56 4% 
     TG 56:1 
      
0.15 1% 0.14 6% 
     TG 58:8 
 
4.2 1% 3.2 19% 
          TG 58:7 
 
4.1 3% 3.1 18% 
          TG 58:3 
      
0.50 2% 0.49 5% 
     TG 58:2 
      
0.29 3% 0.29 5% 
     TG 60:4 
      
0.15 3% 0.15 8% 
     TG 60:3             0.35 8% 0.33 12%           
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Table 3.7 CV of intraday and day-to-day precision of Cer species determined as [M+HCOO]- in human serum, human fibroblast cell 
homogenates, and murine liver samples by FIA-FTMS. 
  
Human serum 
 
Human fibroblast cells 
 
Murine liver 
  
Intraday precision Day-to-day precision 
 
Intraday precision Day-to-day precision 
 
Intraday precision Day-to-day precision 
Species   
Mean  
n=5 
[nmol/mL] 
CV 
Mean  
n=5 
[nmol/mL] 
CV   
Mean  
n=5 
[nmol/mg 
protein] 
CV 
Mean  
n=5 
[nmol/mg 
protein] 
CV   
Mean  
n=5 
[nmol/mg 
wet weight] 
CV 
Mean  
n=5 
[nmol/mg 
wet weight] 
CV 
Cer 34:1;2 
      
0.23 2% 0.23 5% 
 
25 4% 26 3% 
Cer 36:1;2 
           
4.3 6% 4.4 6% 
Cer 38:1;2 
           
3.1 5% 3.4 7% 
Cer 40:2;2 
           
4.3 5% 4.3 6% 
Cer 40:1;2 
 
0.92 4% 0.98 7% 
      
7.9 3% 8.7 5% 
Cer 41:1;2 
 
0.91 4% 0.98 5% 
      
2.8 9% 2.8 5% 
Cer 42:2;2 
 
1.7 6% 1.8 7% 
 
0.32 3% 0.33 5% 
 
33 5% 33 4% 
Cer 42:1;2 
 
2.7 5% 2.8 3% 
 
0.20 6% 0.21 6% 
 
26 4% 26 4% 
Cer 44:2;2             0.048 7% 0.050 5%           
  
  
 
[8
8
] 
3
.3
 M
e
th
o
d
 V
a
lid
a
tio
n
 
Table 3.8 CV of intraday and day-to-day precision of LPC species [M+HCOO]- and LPE species [M-H]- determined in human serum, 
human fibroblast cell homogenates (only LPC), and murine liver samples by FIA-FTMS. 
  
Human serum 
 
Human fibroblast cells 
 
Murine liver 
  
Intraday precision Day-to-day precision 
 
Intraday precision Day-to-day precision 
 
Intraday precision Day-to-day precision 
Species   
Mean  
n=5 
[nmol/mL] 
CV 
Mean  
n=5 
[nmol/mL] 
CV   
Mean  
n=5 
[nmol/mg 
protein] 
CV 
Mean  
n=5 
[nmol/mg 
protein] 
CV   
Mean  
n=5 
[nmol/mg 
wet weight] 
CV 
Mean  
n=5 
[nmol/mg 
wet weight] 
CV 
LPC 16:1 
 
3.4 2% 3.7 6% 
 
1.4 3% 1.3 6% 
 
0.16 2% 0.16 4% 
LPC 16:0 
 
157 2% 173 6% 
 
0.84 3% 0.85 5% 
 
1.39 3% 1.34 3% 
LPC 17:0 
 
3.0 2% 3.3 5% 
          LPC 18:2 
 
54 2% 55 4% 
 
0.50 3% 0.52 5% 
 
0.052 3% 0.047 9% 
LPC 18:1 
 
34 2% 36 5% 
 
3.6 3% 3.6 7% 
 
0.29 3% 0.28 3% 
LPC 18:0 
 
52 1% 57 7% 
      
0.49 4% 0.49 3% 
LPC 20:4 
 
10 1% 11 3% 
          LPC 20:3 
 
2.9 4% 3.1 7% 
          LPE 16:1 
 
0.37 3% 0.38 6% 
      
0.048 4% 0.048 5% 
LPE 16:0 
           
0.31 1% 0.29 6% 
LPE 18:2 
           
0.032 4% 0.031 8% 
LPE 18:1 
 
2.4 2% 2.4 4% 
      
0.39 4% 0.36 9% 
LPE 18:0 
 
0.59 5% 0.60 9% 
      
0.43 2% 0.40 7% 
LPE 20:4 
 
0.95 3% 0.90 2% 
          LPE 22:6   0.55 8% 0.50 7%                     
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Table 3.9 CV of intraday and day-to-day precision of PC and PC O- species determined as [M+HCOO]- in human serum, human 
fibroblast cell homogenates, and murine liver samples by FIA-FTMS. 
  
Human serum 
 
Human fibroblast cells 
 
Murine liver 
  
Intraday precision Day-to-day precision 
 
Intraday precision Day-to-day precision 
 
Intraday precision Day-to-day precision 
Species   
Mean  
n=5 
[nmol/mL] 
CV 
Mean  
n=5 
[nmol/mL] 
CV   
Mean  
n=5 
[nmol/mg 
protein] 
CV 
Mean  
n=5 
[nmol/mg 
protein] 
CV   
Mean  
n=5 
[nmol/mg 
wet weight] 
CV 
Mean  
n=5 
[nmol/mg 
wet weight] 
CV 
PC 30:0 
 
3.0 3% 3.2 2% 
 
4.1 2% 4.0 4% 
 
0.62 2% 0.63 2% 
PC 32:2 
 
2.7 4% 2.8 5% 
 
2.2 2% 2.2 6% 
 
0.049 5% 0.045 4% 
PC 32:1 
 
13 4% 13 5% 
 
14 2% 14 4% 
 
1.9 2% 1.9 3% 
PC 32:0 
 
12 3% 12 6% 
 
4.8 2% 4.9 4% 
 
3.9 3% 3.9 4% 
PC 33:1 
 
3.5 3% 3.9 6% 
 
1.0 3% 1.0 2% 
 
0.026 5% 0.027 9% 
PC 33:0 
      
0.26 5% 0.26 7% 
 
0.026 3% 0.024 16% 
PC 34:4 
           
0.015 4% 0.013 11% 
PC 34:3 
 
15 3% 15 4% 
 
0.84 4% 0.81 6% 
 
0.018 3% 0.016 11% 
PC 34:2 
 
458 2% 494 5% 
 
11 2% 11 5% 
 
0.59 2% 0.57 5% 
PC 34:1 
 
238 2% 241 6% 
 
29 1% 29 5% 
 
1.4 2% 1.5 4% 
PC 35:5 
      
4.2 3% 4.1 8% 
     PC 35:4 
      
1.8 4% 1.7 7% 
     PC 35:2 
 
9.9 2% 10.8 5% 
 
0.80 5% 0.75 11% 
     PC 35:1 
 
4.3 5% 4.4 3% 
 
0.82 1% 0.79 4% 
     PC 36:5 
 
24 1% 23 7% 
 
0.29 2% 0.26 9% 
     PC 36:4 
 
195 2% 202 4% 
 
0.88 1% 0.88 5% 
 
0.074 3% 0.065 11% 
PC 36:3 
 
125 3% 125 6% 
 
3.2 2% 3.1 5% 
 
0.047 3% 0.042 7% 
PC 36:2 
 
251 1% 261 5% 
 
15 1% 16 4% 
 
0.24 2% 0.23 5% 
PC 36:1 
 
31 3% 34 5% 
 
5.0 1% 5.1 5% 
 
0.24 1% 0.23 6% 
PC 37:2 
      
0.37 2% 0.35 13% 
     PC 38:6 
 
67 3% 69 6% 
 
0.34 2% 0.35 5% 
 
0.013 6% 0.013 14% 
PC 38:5 
 
56 1% 54 7% 
 
0.76 1% 0.73 6% 
     PC 38:4   101 3% 105 4%   1.0 3% 1.0 7%   0.058 2% 0.050 10% 
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Human serum 
 
Human fibroblast cells 
 
Murine liver 
  
Intraday precision Day-to-day precision 
 
Intraday precision Day-to-day precision 
 
Intraday precision Day-to-day precision 
Species   
Mean  
n=5 
[nmol/mL] 
CV 
Mean  
n=5 
[nmol/mL] 
CV   
Mean  
n=5 
[nmol/mg 
protein] 
CV 
Mean  
n=5 
[nmol/mg 
protein] 
CV   
Mean  
n=5 
[nmol/mg 
wet weight] 
CV 
Mean  
n=5 
[nmol/mg 
wet weight] 
CV 
PC 38:3 
 
31 1% 32 5% 
 
1.2 2% 1.2 4% 
 
0.024 2% 0.022 4% 
PC 38:2 
      
1.6 2% 1.6 4% 
 
0.020 5% 0.018 4% 
PC 38:1 
           
0.013 3% 0.012 11% 
PC 39:3 
 
3.8 5% 3.8 2% 
 
1.9 2% 2.0 6% 
 
0.072 4% 0.068 17% 
PC 40:7 
 
4.3 3% 4.2 13% 
          PC 40:6 
 
22 2% 21 7% 
 
0.28 1% 0.29 9% 
     PC 40:5 
 
10 4% 10 6% 
          PC 40:4 
 
2.8 5% 2.9 11% 
          PC O-32:3 
      
0.34 3% 0.34 7% 
     PC O-32:2 
      
0.25 6% 0.26 7% 
     PC O-32:1 
      
0.74 2% 0.77 5% 
 
0.13 2% 0.13 4% 
PC O-32:0 
      
0.55 4% 0.54 7% 
 
0.034 3% 0.034 4% 
PC O-34:3 
 
6.1 1% 6.5 5% 
          PC O-34:2 
 
5.3 5% 5.4 7% 
 
0.54 2% 0.54 2% 
 
0.022 3% 0.022 5% 
PC O-34:1 
 
3.2 2% 3.4 5% 
 
1.3 3% 1.3 3% 
 
0.036 3% 0.035 4% 
PC O-36:5 
 
8.6 2% 8.8 6% 
          PC O-36:4 
 
11 3% 11 5% 
          PC O-36:3 
 
3.3 3% 3.6 7% 
 
0.27 5% 0.26 4% 
     PC O-36:2 
      
0.58 1% 0.57 4% 
     PC O-36:1 
      
0.47 3% 0.46 10% 
     PC O-38:6 
 
4.5 3% 4.6 8% 
          PC O-38:5 
 
11 3% 12 5% 
          PC O-38:4   5.2 2% 5.3 6%                     
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Table 3.10 CV of intraday and day-to-day precision of PE and PE O- species determined as [M-H]- in human serum, human 
fibroblast cell homogenates, and murine liver samples by FIA-FTMS. 
  
Human serum 
 
Human fibroblast cells 
 
Murine liver 
  
Intraday precision Day-to-day precision 
 
Intraday precision Day-to-day precision 
 
Intraday precision Day-to-day precision 
Species   
Mean  
n=5 
[nmol/mL] 
CV 
Mean  
n=5 
[nmol/mL] 
CV   
Mean  
n=5 
[nmol/mg 
protein] 
CV 
Mean  
n=5 
[nmol/mg 
protein] 
CV   
Mean  
n=5 
[nmol/mg 
wet weight] 
CV 
Mean  
n=5 
[nmol/mg 
wet weight] 
CV 
PE 32:1 
      
1.1 1% 1.1 3% 
 
0.028 3% 0.029 4% 
PE 34:2 
 
2.8 1% 2.9 4% 
 
3.8 1% 3.7 3% 
 
0.067 4% 0.065 5% 
PE 34:1 
      
5.1 1% 5.1 5% 
 
0.11 3% 0.11 4% 
PE 36:4 
 
3.8 5% 3.8 7% 
 
0.68 2% 0.67 6% 
 
0.046 4% 0.040 11% 
PE 36:3 
 
2.2 4% 2.2 11% 
 
1.9 2% 1.9 4% 
     PE 36:2 
 
9.1 2% 9.0 5% 
 
13 1% 13 3% 
 
0.073 4% 0.071 4% 
PE 36:1 
      
5.0 1% 4.9 4% 
 
0.069 6% 0.072 3% 
PE 38:6 
 
4.5 3% 4.7 6% 
 
0.56 3% 0.57 3% 
 
0.023 4% 0.020 15% 
PE 38:5 
 
2.8 5% 3.1 11% 
 
2.1 2% 2.2 3% 
     PE 38:4 
 
9.6 2% 9.8 6% 
 
3.6 1% 3.5 6% 
 
0.12 4% 0.11 10% 
PE 38:3 
      
1.2 2% 1.2 6% 
     PE 38:2 
      
1.3 4% 1.3 3% 
     PE 40:6 
 
2.6 4% 3.0 6% 
 
0.95 2% 0.99 3% 
 
0.015 7% 0.014 19% 
PE O-32:2 
           
0.013 4% 0.012 7% 
PE O-32:1 
           
0.018 5% 0.020 12% 
PE O-34:3 
      
0.37 5% 0.37 5% 
 
0.023 6% 0.022 7% 
PE O-34:2 
      
1.6 3% 1.6 6% 
 
0.13 2% 0.13 4% 
PE O-36:4 
      
0.50 2% 0.51 7% 
     PE O-36:3 
 
2.5 2% 2.8 3% 
 
0.81 2% 0.81 6% 
 
0.036 5% 0.034 7% 
PE O-36:2 
      
1.1 2% 1.1 7% 
 
0.054 3% 0.053 4% 
PE O-38:6 
 
7.2 2% 6.9 10% 
          PE O-38:5 
 
8.5 2% 8.5 6% 
 
1.6 3% 1.6 4% 
 
0.092 6% 0.081 12% 
PE O-38:4 
      
0.67 1% 0.68 7% 
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Table 3.11 CV of intraday and day-to-day precision of PG and PI species determined as [M-H]- in human serum, human fibroblast 
cell homogenates (only PI), and murine liver samples by FIA-FTMS. 
  
Human serum 
 
Human fibroblast cells 
 
Murine liver 
  
Intraday precision Day-to-day precision 
 
Intraday precision Day-to-day precision 
 
Intraday precision Day-to-day precision 
Species   
Mean  
n=5 
[nmol/mL] 
CV 
Mean  
n=5 
[nmol/mL] 
CV   
Mean  
n=5 
[nmol/mg 
protein] 
CV 
Mean  
n=5 
[nmol/mg 
protein] 
CV   
Mean  
n=5 
[nmol/mg 
wet weight] 
CV 
Mean  
n=5 
[nmol/mg 
wet weight] 
CV 
PG 30:0 
           
0.010 2% 0.010 6% 
PG 32:1 
           
0.056 2% 0.059 6% 
PG 32:0 
           
0.13 2% 0.14 4% 
PG 34:2 
 
0.18 5% 0.18 6% 
      
0.089 2% 0.096 7% 
PG 34:1 
 
0.74 3% 0.74 2% 
      
0.27 1% 0.30 9% 
PG 36:2 
 
0.84 2% 0.83 1% 
      
0.017 3% 0.019 16% 
PG 36:1 
 
0.38 5% 0.41 4% 
      
0.016 6% 0.018 13% 
PG 38:7 
 
1.3 6% 1.4 11% 
      
0.078 9% 0.090 23% 
PG 40:7 
 
0.48 3% 0.51 6% 
          PI 34:2 
      
0.88 3% 0.84 4% 
     PI 34:1 
 
4.1 6% 4.0 9% 
 
2.3 2% 2.2 6% 
 
0.050 8% 0.051 26% 
PI 36:4 
      
0.28 4% 0.29 6% 
 
0.029 5% 0.029 11% 
PI 36:3 
      
0.67 3% 0.69 2% 
     PI 36:2 
 
6.9 4% 7.0 5% 
 
2.7 3% 2.9 2% 
 
0.028 7% 0.030 12% 
PI 36:1 
 
3.1 4% 3.1 11% 
 
3.5 4% 3.6 2% 
     PI 38:4 
 
32 4% 32 7% 
 
4.7 4% 5.0 3% 
 
0.34 5% 0.37 13% 
PI 40:6 
      
0.46 5% 0.47 4% 
     PI 40:4             0.40 3% 0.41 4%           
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3.3.2 Limits of Quantification 
The LOQs were determined functionally as described in the experimental 
section (2.6.4 Method Validation) for the main lipid classes of human plasma. 
However, since it is known that sample matrix can have a substantial influence 
on the LOQ, it was also assessed for FC and CE in cultured human skin 
fibroblast cell matrix. The LOQ was defined as concentration where either CV 
reached 20% or accuracy left the range of 80-120%. The concentrations of LOQ 
at accuracy and CV are summarized in Table 3.12. The corresponding data are 
displayed in Figure 3.33 (FC and CE in fibroblast cells), Figure 3.34 (FC and CE 
in serum), and Figure 3.35 (DG, TG, and PC in serum). The LOQs of CE, DG, 
PC, and TG are low enough for accurate and reliable quantification of main lipid 
species in human plasma, serum, and fibroblast cell matrix. However, the LOQs 
of FC in plasma (with approximate 200 µM) and cell matrix (14 nmol/mg protein) 
are rather high. This is related to the poor ionization efficiency and high rate of 
in-source fragmentation. Nevertheless, we would like to emphasize that FC is a 
main component in most mammalian samples with concentrations markedly 
higher than the LOQ. Thus, despite the high LOQ, MSX can provide accurate 
quantification of FC in typical samples as shown in Table 3.4. 
 
Table 3.12 LOQ of CE, DG, FC, PC, and TG at accuracy (Acc.) and CV for 
human plasma and/or cultured human fibroblast cell matrix determined by FIA-
FTMS and FIA-MSX/FTMS. 
  
CE 
 
DG 
 
FC 
 
PC 
 
TG 
Matrix Unit Acc. CV   Acc. CV   Acc. CV   Acc. CV   Acc. CV 
Plasma [nmol/mL] 1.9 1.4 
 
2.9 1.5 
 
198 65 
 
2.3 0.57 
 
0.48 0.48 
Cells 
[nmol/mg 
protein] 
0.05 0.01 
 
- - 
 
4.5 14 
 
- - 
 
- - 
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Figure 3.33 Limit of quantification of (A) FC, and (B) CE determined in human 
fibroblast cells. The left panel shows the absolute values of accuracy-100, and 
the right panel the measured CV’s against the target concentration. 
Homogenates of cultured human fibroblasts were spiked with (A) D7-FC and (B) 
CE 22:0 as non-endogenous species at displayed concentration levels. Results 
were fit by a power function. Each data point was calculated from n=5 technical 
replicates. 
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Figure 3.34 Limit of quantification of (A) FC, and (B) CE determined in human 
serum. The left panel shows the absolute values of accuracy-100, and the right 
panel the measured CV’s against the target concentration. Human serum was 
spiked with (A) D7-FC and (B) CE 22:0 as non-endogenous species at 
displayed concentration levels. Results were fit by a power function. Each data 
point was calculated from n=5 technical replicates. 
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Figure 3.35 Limit of quantification of (A) DG, (B) TG, and (C) PC determined in 
human serum. The left panel shows the absolute values of accuracy-100, and 
the right panel the measured CV’s against the target concentration. Human 
serum was spiked with (A) DG 40:0, (B) TG 57:0, and (C) PC 44:0 as non-
endogenous species at displayed concentration levels. Results were fit by a 
power function. Each data point was calculated from n=5 technical replicates. 
  
3.3 Method Validation 
[97] 
 
3.3.3 Dynamic Range of Quantification 
The accurate quantification of lipid species is a major goal of high resolution 
shotgun lipidomics approaches. To evaluate the dynamic range of quantification 
of FIA-FTMS, synthetic standards without matrix and spiked on murine liver, 
human plasma, and human skin fibroblast cell samples were analyzed on the Q 
Exactive (Figure 3.36 and Figure 3.37). Over the spiked range a linear increase 
was observed with similar slopes for pure standards and matrix containing 
samples excluding significant effects of the matrix on both linearity and species 
response. Only for LPE 18:1 added to murine liver slope was almost 15% lower 
slope than the expected slope of 1. A potential explanation could be the high 
endogenous amount of this LPE species in the used liver sample or a matrix 
dependent decreased response. 
Notably, the investigated concentration range of each synthetic standard 
comprises very well the typical concentration range observed in biological 
samples. Based on these result we conclude that the FIA-FTMS method on the 
Q Exactive is applicable for quantitative lipidomic analysis of biological samples. 
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Figure 3.36 Dynamic range of quantification of FTMS analysis of (A) LPE 18:1, 
(B) LPC 18:1, (C) DG 36:1, and (D) CE 18:1 using a target resolution of 
140,000 at m/z 200. Each synthetic standard was analyzed (from left to right) 
without matrix, and spiked on murine liver, human plasma and human fibroblast 
cells. The spectra display the correlation of measured and titrated 
concentration. Each data point represents the average of three replicate 
analyses per sample.  
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Figure 3.37 Dynamic range of quantification of FTMS analysis of (A) 
Cer 42:2;2, (B) SM 36:2;2, (C) PC 36:2, and (D) TG 54:1 using a target 
resolution of 140,000 at m/z 200. Each synthetic standard was analyzed (from 
left to right) without matrix (not performed for PC 36:2), and spiked on murine 
liver, human plasma and human fibroblast cells. The spectra display the 
correlation of measured and titrated concentration. Each data point represents 
the average of three replicate analyses per sample. 
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4 Conclusion 
This work describes the development of a flow injection analysis Fourier 
Transform mass spectrometric method (FIA-FTMS) for lipid species 
quantification, which is – to our knowledge – the first application using a 
conventional LC pump system instead of a chip-based nano-flow to infuse 
crude lipid extracts of biological samples. 
In order to achieve precise and reliable quantification, an automated isotope 
correction algorithm was developed. Since isotopic overlap is directly related to 
mass resolution, which decreases for orbitrap mass spectrometer with m/z, the 
correction algorithm was developed and evaluated for various mass ranges at 
the highest mass resolution setting of our instrument (140,000 at m/z 200). An 
unexpected finding was that peak intensities of near isobaric peaks resulting 
from DBA did not represent the intensity of both peaks most likely related to the 
so-called peak coalescence described for FTMS (Kaufmann & Walker, 2012). 
Here, we demonstrated that despite peak coalescence accurate quantification is 
possible for a wide range of lipid species. Thus, type II isotope correction is not 
required for fully overlapping peaks and accuracy of concentrations for partially 
overlapping peaks could be improved by so-called I/A correction (developed in 
this thesis). The I/A correction applies a correction factor calculated with 
intensity and area of the overlapping peaks. These m/z-dependent algorithms 
implemented in an automated data processing in combination with a simple 
sample preparation and short analysis time makes the method suitable for a 
comprehensive high throughput quantification of lipid species in a broad variety 
of biological samples. 
Method comparison to a certified enzymatic test revealed that accurate 
quantification of CE species by FTMS requires utilization of individual species-
specific response factors (illustrated in Figure 4.1). The marked, up to three-
fold, differences in their analytical response are related to structural features, 
like length and double bond number of constituent acyl chains, which affect the 
susceptibility of CE species to undergo in-source fragmentation processes 
during electro-spray-ionization. The comparison with a chip-based infusion 
nano-ESI approach demonstrated that the vast effect of double bond number is 
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not limited to conventional ESI. Remarkably, the response trends observed for 
both ion sources were similar, despite disparate flow rates of 10 µL/min and 
200 nL/min for ESI and nano-ESI, respectively. This indicates that response 
correction is highly relevant and should be considered for different instrumental 
setups, not only for direct infusion methods but also for LC-based quantification. 
However, CE in-source fragmentation as main cause for response differences 
could be influenced by the build of the mass spectrometer, gas flow, and 
temperature. These parameters should also be considered with great care 
when developing lipidomic methods (Gathungu et al., 2018).  
 
Figure 4.1 Schematic illustration of CE response correction. 
 
Recently, Gallego et al. demonstrated superior performance of free cholesterol 
determination by MSX/FTMS in comparison with PRM and direct FTMS 
quantification (Gallego et al., 2017). The evaluation of free cholesterol 
quantification by MSX/FTMS in our setup demonstrated that the method 
provides a high accuracy and reproducibility. Comparison with an acetyl 
chloride derivatization method on a triple-quadrupole mass spectrometer 
(Liebisch et al., 2006) showed very good alignment of both concentrations.  
In summary, validation of the method demonstrated that FIA-FTMS (including 
MSX/FTMS) is applicable for quantification of lipid species in biological samples 
4 Conclusion 
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used in basic science as well as in clinical studies such as cultured cells, tissue 
homogenates, plasma, and serum. 
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